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I. ABSTRACT 
Background: In 1981 , a cohort of 1,0 13 prevalent cases of blindness, registered with the 
CNIB, was studied. Established monogenic disease was the cause of blindness in 24% of 
cases and presumed in a further 6%. Since that original study, considerable new clinical 
information and family history data have been accumulated. In addition, incident cases 
with different causes of inherited blindness have been identified. 
Objectives: To determine: the proportion of cases of blindness attributable to monogenic 
disease after long term follow up; which blindness phenotypes were observed in each 
geographical region ofthe province; whether geographic clustering of specific 
phenotypes occurred; and whether mutation specific disease clustered in particular 
geographic regions. 
Methodologies: In 2007/8 all cases in the 198 1 cohort were reviewed in order to 
detennine the number in whom the clinical diagnosis had changed; the number in whom 
the molecular genetic diagnosis was established; and the number of families avai lable for 
potential novel gene discovery. In addition, the geographic distribution of families with 
various monogenic causes ofblindness was mapped. 
Results: Long tenn follow up revealed that established genetic disease was the cause of 
blindness in 30% of the cohort and a further 12% had presumed genetic disease. 
Geographic clustering was observed with some inherited disorders, and random 
II 
occurrence of others around the coast of Newfoundland. Within various geographic 
regions there were multiple genetic causes of blindness. For example, in Conception Bay 
communities, nine different hereditary eye diseases were identified. 
Conclusions: Newfoundland is a young founder population, consisting of multiple 
genetic isolates, where the peopling of these isolates has predisposed to the frequent 
occurrence of hereditary blindness, associated with multiple different genotypes and 
phenotypes. The genetic architecture of the Newfoundland population has facilitated the 
identification of novel genes and has resulted in families with the potential to facilitate 
further identification of novel genes and mutations causing blindness in Newfoundland in 
the future. 
lli 
II. Acknowledgments 
I wish to thank the following supervisors for their willing and continued 
participation in the development and conclusion of this project. 
Dr. Jane Green and Dr. Patrick Parfrey. 
I would also like to thank several researchers at Memorial University for their past 
and present involvement in genetic research projects which have provided information in 
this thesis. Dr. Brendan Barrett, Dr. Benvon Cramer, Dr. Bryan Curtis, Lance Doucette, 
Dr. Elizabeth Dicks, Dr. Bridget Fernandez, Dr. Roger Green, Dr. John Harnett, Kelly 
Hatch, Dr. Susan Moore, Dr. Sean Murphy, Mike Webb, Dr. Mike Woods, Dr. Ban 
Younghusband, and Dr. Terry Lynn Young. 
IV 
III. List of Tables 
Table l . The chronological development of the human eye, with developmental 24 
milestones and associated gestational age. 
Table 2. Causes of blindness among the persons in Newfoundland, determined 51 
after 27 years follow-up, compared to initial diagnosis made in 1981. 
Table 3. The causes of blindness in 2008 by anatomical location and specific 52 
hereditary disease among the persons in whom a genetic cause was 
established following long term follow-up. 
Table 4. The causes of blindness in 2008 by anatomical location and specific 54 
hereditary disease among the persons in whom a genetic cause was 
presumed following long term follow-up. 
Table 5. Distribution of families with monogenic eye diseases by geographic 55 
region of ancestral home. 
Table 6. Identified genes and mutations in Bardet-Biedl Syndrome, 57 
Newfoundland Rod-Cone Dystrophy, Stargardt Disease, Peters Anomaly, 
and X-linked Ocular Albinism. 
Table 7. Genotypes in Bardet-Biedl Syndrome Families in Newfoundland. 59 
Table 8. Two Splice-Junction Mutations in RLBPJ cause Newfoundland Rod 64 
Cone Dystrophy. 
v 
IV. List of Figures 
Figure 1. The Geographic Distribution ofthe Population ofNewfoundland in 1981. 4 
Figure 2. Autosomal Dominant Inheritance Pedigree. 6 
Figure 3. Autosomal Recessive Inheritance Pedigree. 7 
Figure 4. X-linked Recessive Inheritance Pedigree. 8 
Figure 5. Pseudo-Dominant Inheritance Pedigree. 9 
Figure 6. Mitochondrial Inheritance Pedigree. 11 
Figure 7. Anatomy of the human eye. 14 
Figure 8. Anterior segment of the eye. 15 
Figure 9. Posterior segment ofthe eye. 19 
Figure 10. Mapped and Identified Retinal Disease Genes, 1980-2012. 28 
Figure 11. Pedigrees ofNewfoundland Bardet- Biedl syndrome patients. 58 
Figure 12. The Geographic Distribution (Ancestral Locations) ofBardet-Biedl 61 
Syndrome mutations in Newfoundland. 
Figure 13. The Geographic Distribution (Ancestral Location) of Newfoundland 62 
Rod-Cone Dystrophy in Newfoundland. 
Figure 14. Pedigrees of 6 Newfoundland families diagnosed with Newfoundland 63 
Rod- Cone Dystrophy. 
Figure 15. The Geographic Distribution of Ocular Albinism in Newfoundland. 66 
Figure 16. The Geographic Distribution (Ancestral Locations) of Stargardt Disease 67 
in 22 Newfoundland families, from whom DNA was obtained. 
VI 
---~----------------------------------------------------------------------------------------
Figure 17. The Geographic Distribution (Ancestral Locations) of Anterior 69 
Segment Disorders in Newfoundland. 
Figure 18. The Geographic Distribution (Ancestral Locations) of Retinitis 71 
Pigmentosa in Newfoundland. 
Figure 19. The Geographic Distribution (Ancestral Locations) ofUsher Syndrome 72 
in Newfoundland. 
Figure 20. The Geographic Distribution (Ancestral Locations) of Achromatopsia 73 
in Newfoundland. 
Figure 21. The Geographic Distribution (Ancestral Locations) ofRare Genetic 74 
and Ophthalmic Disorders in Newfoundland. 
Figure 22. The Geographic Distribution (Ancestral Locations) of Oculocutaneous 76 
Albinism in Newfoundland. 
Figure 23. The Geographic Distribution (Ancestral Locations) of Retinoblastoma 78 
in Newfoundland. 
Figure 24. Extended multigenerational pedigree of a Newfoundland family with 82 
Ocular Albinism. 
Figure 25 . Anatomical layers of the retina. 116 
VII 
--- --- ------------------------- --------------- ----, 
Table of Contents: 
I. Abstract 
II. Acknowledgments 
III. List ofTables 
IV. List of Figures 
V. Introduction 
i. Population ofNewfoundland 
ii. Monogenic Disease 
iii. Literature Search (Search Strategy) 
iv. Development of the Eye 
v. Hereditary Eye Disease 
VI. Research Objectives 
VII. Hypotheses 
VIII. Subjects and Methods 
IX. Results 
X. Discussion 
XI. Conclusion 
XII. References 
XIII. Appendix 
A. Anatomy of the Eye 
B. Previous Newfoundland Studies: Literature Review 
VIII 
II 
IV 
v 
VI 
1 
5 
12 
13 
25 
44 
45 
46 
50 
81 
91 
93 
111 
11 2 
118 
Hereditary diseases as causes of blindness in Newfoundland: 
A cohort study with long term follow up. 
V. INTRODUCTION 
i. Population of Newfoundland 
The Canadian province ofNewfoundland and Labrador lies on the most easterly 
point ofNorth America. The island portion of the province, Newfoundland, has an 
estimated population of 508,099 (I). The total land area of 405,212 km2 (3 73,872 km2 of 
Land and 31,340 km2 of water), has a low population density of 1.35 persons /km2 • 90% 
of Newfoundland's population has descended from about 30,000 founders who settled in 
Newfoundland at the end of the 18th and the start ofthe 19th century. These founders 
included mainly Protestant settlers from the south-west of England and Roman Catholic 
settlers from the south east of Ireland (2). 
The population of Newfoundland has arisen by natural increase from settlers who 
arrived before 1835, drawn from these highly circumscribed areas of south-western 
England and southern Ireland. Hundreds of small communities have grown up around 
Newfoundland's many natural harbours. At present, about 50% of the population of the 
province reside in communities of fewer than 2,500 inhabitants, and 41% reside in 
communities of fewer than 1,000 inhabitants (3,4). Closely consanguineous unions tend 
to be avoided, but matings may occur between distant relatives. The frequency of some 
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recessive disorders at increased frequency may be attributed to a founder effect (the 
chance presence of an allele in relatively few original settlers that has become common in 
a genetically isolated population). In addition, the large family size down the generations, 
and the tendency of descendants to settle near the same community, has produced large 
numbers of people with specific autosomal dominant disorders. 
The geographic distribution ofthe population ofNewfoundland in 1981 , from 
information gathered from Statistics Canada, is shown in Figure 1 ( l ). Few people live in 
the interior of the island. The four cities, identified with black dots on the Trans Canada 
highway, are shown with their own numerical population and not included within the 
surrounding coastal areas. The remainder of the population is generally distributed 
around the coast ofNewfoundland. 
Geographic distance between settlements is a major determinant of genetic 
isolation (4). As about fifty percent of the population ofNewfoundland resides in rural 
communities with 2,500 inhabitants or less, and as the average kinship between 
subpopulations generally decreases with the increased distance between them ( 4), it is not 
surprising that certain autosomal recessive conditions occur at increased frequency. 
The geography, settlement, and socioeconomic development of Newfoundland 
have produced a population in which certain monogenic diseases occur frequently. As a 
result, important observations can be made on the clinical manifestations and outcomes of 
Mendelian inherited diseases, and examination of DNA for mutations in genes can 
provide mechanistic insights into the molecular determinants of the diseases (5). There 
were 27 entries in Online Mendelian Inheritance of Man (www3.ncbi.nlm.nih.gov/omim/) 
in 2003 whose genetic basis was elucidated using Newfoundland families ( 4). This 
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number of entries is 10-fold higher than that of the neighboring three provinces (Nova 
Scotia, New Brunswick and Prince Edward Island), when adjusted for population size (4). 
This thesis will provide information on the clinical and genetic epidemiology of 
inherited eye diseases within Newfoundland through the review of pedigrees, current 
clinical information and previous molecular genetic studies undertaken in a cohort of 
patients identified nearly 30 years ago. 
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Figure 1: The Geographic Distribution of the Population ofNewfoundland in 1981. 
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ii. Monogenic Disease 
Monogenic causes of inherited blindness may result from autosomal dominant, 
autosomal recessive, X-linked, or mitochondrial inheritance. Establishing the inheritance 
pattern of a disease is initially through the analysis of a patient's family history, 
diagrammed in a pedigree (6,7,8). 
Autosomal Dominant 
An autosomal dominant disease results from a single abnormal gene inherited 
from either parent. The disease is typically observed in multiple generations (Figure 2) 
because affected individuals who receive a disease-causing mutation from an affected 
parent may pass this on to their offspring. Since these genes are located on autosomes, 
males and females are affected in roughly equal frequencies (6,7,8). Skipping of 
generations may be observed in a pedigree, when there is reduced or incomplete 
penetrance. A disease-causing mutation is said to have reduced or incomplete penetrance 
when some individuals who have the disease genotype (one copy of the mutation for an 
autosomal dominant disease or two copies for an autosomal recessive disease) do not 
display the disease phenotype (6,7,8). 
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Figure 2. Autosomal Dominant Inheritance Pedigree was reproduced with consent from 
Dr. Tracey Weiler, Professor of Genetics, The Medical University of the Americas. 
Autosomal Recessive 
Autosomal recessive alleles are clinically expressed only in the homozygous state. 
Therefore, the offspring must inherit one copy of the disease-causing allele from each 
parent. Individuals with only one defective gene are considered carriers and they can 
pass the abnormal gene to their children. Most commonly, a homozygous or compound 
heterozygous affected individual results from the union of two heterozygous (carrier) 
parents. However, if an affected homozygote mates with a heterozygote, this could also 
produce an affected offspring (7 ,8). 
In contrast to autosomal dominant diseases, autosomal recessive diseases are 
typically seen in only one generation of a pedigree (Figure 3). Consanguinity, the mating 
of related individuals (represented by the double line in the pedigree), is sometimes seen 
in recessive pedigrees because individuals who share common ancestors are more likely 
to carry the same recessive disease-causing alleles. 
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Figure 3. Autosomal Recessive Inheritance Pedigree was reproduced with consent from 
Dr. Tracey Weiler, Prof essor of Genetics, The Medical University of the Americas. 
X-Linked 
X-linked inherited diseases result from mutations on the X-chromosome. Since 
males have only one copy of the X chromosome, if a recessive disease-causing mutation 
occurs on the X chromosome, the male will be affected with the disease (6). Normal 
females have two copies of the X chromosome, so they usually require two copies of the 
mutation to express the disease (6,7,8). However, because X inactivation (described 
below), is a random process, a heterozygous female will occasionally express an X-linked 
recessive condition since, by random chance, most of the X chromosomes carrying the 
normal allele have been inactivated. Such a female is termed as a manifesting 
heterozygote, and since they usually have at least a small population of active X 
chromosomes carrying the normal allele, their disease expression is typically milder than 
that of a male (6,7,8). 
- 7 -
Since males require only one copy of the mutation to express the disease, whereas 
females require two copies, X-linked recessive diseases are seen much more commonly in 
males than in females (Figure 4). Skipped generations are commonly seen because an 
affected male can transmit the disease-causing mutation to a heterozygous daughter, who 
is unaffected (carrier), but who can transmit the disease-causing allele to her sons. Male-
to-male transmission is not seen in X-linked inheritance, which helps to distinguish it 
from autosomal inheritance (7,8). 
X inactivation occurs very early in the development of female embryos. When an 
X chromosome is inactivated, its DNA is not transcribed into mRNA (7,8). Males inherit 
an X chromosome from their mother and a Y chromosome from their father, whereas 
females inherit an X chromosome from each parent. The X inactivation results in a more 
balanced functioning of the X linked genes. In a carrier female, if the chromosome with 
the normal gene is inactivated in relevant tissues, the female could express the disease (7). 
I 
II 
III 
Figure 4. X-linked Recessive Inheritance Pedigree was reproduced with consent from Dr. 
Tracey Weiler, Professor a_[ Genetics, The Medical University of the Americas. 
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There is also an inheritance pattern known as X-linked Dominant, however very 
few diseases meet this classification (8). 
Pseudo-Dominant Inheritance 
Pseudo-dominant inheritance mimics autosomal dominant inheritance, a potential 
pitfall when establishing autosomal dominant inheritance, therefore observation of 
additional family members must be completed to distinguish the inheritance (Figure 5). 
Pseudo-dominance can occur with mating between an affected individual of an autosomal 
recessive trait and an individual heterozygous for the autosomal recessive mutation. With 
this mating there is a 50% risk that any offspring will be affected as in AD inheritance, 
but this pattern will be in this generation only (7,8). 
A la a l a 
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Figure 5. Pseudo-Dominant Inheritance Pedigree was reproduced with consent from Dr. 
Jane Green, Professor of Genetics, Memorial University of Newfoundland. 
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Mitochondrial 
Mitochondrial inherited diseases result from mutations in the mitochondrial DNA 
(mtDNA) that affects mitochondria function. Mitochondria are normal structures or 
organelles, located within a cell's cytoplasm, outside of the nucleus, and are primarily 
responsible for energy production through oxidative phosphorylation (5). Each 
mitochondrion has a chromosome that is made of mtDNA but is otherwise quite different 
from the regular chromosomes within the nucleus of cells. The mitochondrial 
chromosome is much smaller, round in shape, and there are many copies in every cell, 
whereas, the regular chromosomes are much larger, rod shaped, and there is normally 
only one set of chromosomes in the nucleus (8). 
Mitochondrial inheritance is sometimes referred to as maternal inheritance since 
mtDNA is strictly inherited from the mother, because sperm cells contribute no 
mitochondria to the egg cell during fertilization. Therefore, people affected with a 
mitochondrial disease may be male or female but they are always related in the maternal 
genetic line (Figure 6). None of the offspring of an affected male can be affected (7 ,8). 
A typical cell contains hundreds of mitochondria in its cytoplasm. Sometimes a 
specific mutation is seen in only some of the mitochondria, a condition known as 
heteroplasmy. Variations in heteroplasmy can result in substantial variation in the 
severity of expression of mitochondrial diseases. Leber Hereditary Optic Neuropathy is 
the only mitochondrial inherited eye disease and heteroplasmy is relatively uncommon 
for this disease, so affected individuals tend to have similar levels of expression (8). 
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Figure 6. Mitochondria/Inheritance Pedigree was reproduced with consent from Dr. 
Tracey Weiler, Professor of Genetics, The Medical University of the Americas. 
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iii. Literature Search 
A literature search was conducted through The National Library of Medicine 
using PubMed, Medline, and the Cochrane Collection databases. Specific search terms 
were used to help locate pertinent articles regarding heritable eye disease within 
Newfoundland and other communities, as well as the anatomy, genetics, and development 
of the eye including: heritable eye disease, genetic eye disease, epidemiology, ocular 
manifestations, genetics, and Newfoundland population. Also used were the specific eye 
diseases including: Retinitis Pigmentosa, Bardet-Biedl Syndrome, Cone Dystrophy, 
Cone-Rod Dystrophy, Newfoundland Rod-Cone Dystrophy, Achromatopsia, Leber 
Congenital Amaurosis, Leber Hereditary Optic Neuropathy, Optic Atrophy, Stargardt 
Disease, Usher Syndrome, Aniridia, Corneal Dystrophy, Cataracts, Ocular Albinism, 
Oculocutaneous Albinism, Microphthalmia, Retinoblastoma, Coloboma, Anophthalmia, 
Myopia, Glaucoma, and Peters Anomaly. Websites including: Statistics Canada 
(www.statcan.ca), University of Maryland Medical Centre website (www.umm.edu), and 
The Nuffield Council on Bioethics (www.nuffieldbioethics.org) were referenced for past 
and present population statistics and up to date medical definitions and guidelines. A 
manual search of recent articles and text books in the Health Sciences Centre Library was 
perfonned, and also a solicitation of an ocular geneticist for recent pertinent literature was 
done. The searches provided a tremendous amount of information regarding all facets of 
the eye. Several of the key articles' reference lists were checked and cross-referenced 
with those already located to establish if other pertinent papers could be located. Experts 
in the area of inherited eye disease and epidemiology were asked for input as well as 
abstracts from conferences for the last several years were reviewed for relevant articles. 
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iv. Development of the Eye 
The visual system is the principal method for acquiring external sensory 
information in humans. The anatomy of the eye is outlined in Appendix A. The basic 
components of the optic system are derived from four embryonic sources: a) forebrain 
neuroectoderm, b) intercalating mesoderm, c) surface ectoderm, and d) neural crest. The 
neuroectoderm contributes cells for the formation of the retina, iris, and optic nerve; the 
surface ectoderm gives rise to lens and corneal epithelium; the mesoderm differentiates 
into the extraocular muscles and the fibrous and vascular coats of the eye; and neural 
crest cells become the corneal stroma, sclera and corneal endothelium (9, 1 0). 
The genes that are expressed in a cell collectively determine its primary features: 
its potential to grow and divide, its shape, its capacity for movement, and specific 
metabolic functions. Also, the expressed genes determine what signals the cell can send 
and receive to and from other cells (11 ). Genetic regulation is critical to ocular 
development. Two genes that are very important in ocular development are the P AX6 
gene and the Rx gene. Induction of Rx and PAX6 genes during early embryogenesis 
initiates a cascade of gene activation and depression that leads to the formation of the 
mature eye. From the early stages of retinal development to the final mitotic divisions of 
the differentiating retina, Rx and PAX6 are expressed in proliferating cells (12). PAX6 
has been considered a "master control gene" for ocular development. Its sequence has 
been conserved throughout evolution. The human protein is identical to that of mice and 
is almost identical to that offish and chickens (13). 
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The human eye is a complex organ, with many structures working together to give 
us the sense of sight, allowing us to observe and learn about the surrounding world 
(Figure 7). It can be divided into two segments, which are anterior and posterior. 
sclere 
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Figure7. Anatomy of the human eye, figure was reproduced from Encyclopedia Britannica. 
The Globe 
The eye starts to develop from neuroectoderm around the twenty-second day of 
fetal life when the optic primordium is first identified as the optic pits - paired structures 
on both sides of the midline in the ventrolateral region ofthe primitive forebrain (12). 
The optic pits extend outward to form the optic vesicles that are connected to the 
forebrain by the optic stalk. By the fifth week of development, the optic cup has formed 
from the invagination of the optic vesicle. The optic cup forms a fold known as the 
embryonic fissure, through which the mesenchymal and vascular tissues enter the globe. 
Closure of the embryonic fissure begins midway in the fissure and then extends anteriorly 
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and posteriorly, completing the process by the end of the seventh week of gestation (12). 
Incomplete closure of the fissure leads to formation of colobomas ofthe iris, retina, or 
choroid (12). 
The fetal eye demonstrates rapid growth between the eighth and fourteenth weeks 
of life. The growth of the eye overall parallels the growth of the embryo until the thirtieth 
week, after which the eye growth begins to slow (12). 
The Anterior Segment 
The anterior segment is the front third of the eye that includes the structures in 
front of the vitreous humour: the cornea, aqueous humour, iris, ciliary body, lens, 
zonules, and pupil (Figure 8). 
The Anterior Segment 
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Figure 8. Anterior segment of the eye, figure was reproduced from Encyclopedia Britannica. 
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The Cornea 
The cornea develops from three waves of neural crest-derived perilimbal 
mesenchymal cells that migrate between the lens and the acellular stroma at six weeks of 
gestation (12, 14 ). Most of the corneal development occurs between the sixth week and 
fifth month of fetal life. The cornea is initially transparent and retains the uniform 
arrangement of parallel bundles and lamellae of collagen that allows for transparency 
( 12). The collagen fibers are arranged with respect to one another and interact with 
proteoglycans in such a way as to form a mechanically strong extracellular matrix that 
does not scatter light, allowing transmittance of more than 99% of incident visible 
radiation ( 14 ). 
The Iris 
After six to eight months of gestation, the iris dilator and sphincter muscles 
develop from neuroectoderm. The iris vasculature derives from the mesoderm, and the 
iris stroma forms from the neural crest. At birth, the iris in many infants appears gray or 
blue, largely because of a lack of pigment in the iris stroma and the pigment epithelium. 
Iris color typically darkens during the first year of life (12). 
The Lens 
The cells that form the crystalline lens develop from the surface ectoderm 
covering the head of the embryo. After the optic vesicles and the prospective lens cells 
make contact they secrete an extracellular matrix that causes them to bind tightly with 
each other. The surface epithelial cells that adhere to the optic vesicle then elongate to 
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form the lens placode. Shortly after, the lens placode and adjacent cells of the optic 
vesicle buckle inwards resulting in the formation of the optic cup from the optic vesicle. 
After this lens invagination, the extracellular matrix between the optic vesicle and the lens 
begins to dissolve and the tissues separate. This space formed by the separation of the 
two tissues is the primary vitreous body, which is filled with a loose extracellular matrix 
(12, 15). 
The epithelial cells that give rise to the lens vesicle originally lie on a thin basal 
lamina which comes to surround the lens vesicle during the process of invagination and 
eventually forms the lens capsule. Soon after, the lens vesicle separates from the surface 
ectoderm and the cells begin to elongate into the primary fiber cells which establish the 
fundamental lens structure. Cells at the margin of the epithelium are stimulated to 
differentiate into secondary fibers cells which continue to form the final structure of the 
adult lens (12, 15). 
The Pupil 
After six to eight months of gestation, the sphincter and dilator muscles that 
control the pupil are derived from the pigment cells of the neuroectoderm (16). The pupil 
can be very useful in a clinical setting due to the fact that it acts as an objective indicator 
of the amount of light transduction by the visual system. The amount of transient pupil 
contraction to a light stimulus or the steady state diameter of the pupil under constant 
illumination can reflect the health of the retina and the optic nerve and can be used to 
detect disease ( 17). 
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The Ciliary Muscle 
The ciliary muscle develops from mesenchyme (embryonic connective tissue), 
situated at the edge of the optic cup. During the fourth month of gestation the muscle 
becomes organized into fibers and strands ( 18). Circular fibers appear on the inner 
anterior aspect of the meridional (middle) muscle by the seventh month and continue to 
increase in size but are still not completely formed at birth ( 18). 
The Zonule of Zinn 
Zonular fibers are initially seen at the end of the third fetal month. The primary 
cells responsible for the secretion of the zonules are the ciliary and lens epithelium ( 1 0). 
The zonules arise from their posterior insertion at the pars plana region of the ciliary body 
(19). The zonule fibers form sheets or ribbon-like structures because of the mucus 
associated with them (18). 
The Posterior Segment 
The posterior segment comprises the remaining internal structures which lie 
posterior to the anterior segment. This includes: the retina, macula, fovea, sclera, 
choroid, vitreous humour, and optic nerve (Figure 9). 
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The Posterior Segment 
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Figure 9. Posterior segment of the eye, .figure was reproduced from Encyclopedia Britannica. 
The Retina 
The retina is one of the most interesting parts of the eye for clinicians and 
scientists to study due to the fact that as much as 80% of the sensory input in humans 
takes place through the retina, engaging about one third of the human brain for its 
processing. Also the retina is the simplest and best organized part of the central nervous 
system (CNS). It can reflect changes in the cardiovascular system, where it shows 
vascular changes in hypertension and diabetes. Changes in intracranial pressure can also 
be observed (18,20). 
The retina develops from the neuroectoderm following the formation of the optic 
cup. The invaginating portion or inner wall ofthe cup gives rise to the neural retina 
whereas the outer wall produces the retinal pigment epithelium. The retina in its 
primitive state consists of 8 to 10 layers of cells with oval nuclei. The earliest cells to 
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differentiate in the retina are the retinal ganglion cells, and the last cells to differentiate 
are the rods and cones (21 ,22). 
The initial stage of development is the differentiation of the columnar cells of the 
optic vesicle into a two-layered tissue known as the "neuroepithelium". This stage of 
development commences at the same time as the invagination of the optic vesicle in the 
embryo (18,23). From the sixth to the twelfth week the "neuroepithelium" gradually 
develops into the neuroblastic layers (23). The mature retina subsequently develops from 
these neuroblastic layers (23). The development follows with the differentiation of the 
neural elements from the inner and outer neuroblastic layers. Next is the creation of the 
inner nuclear layer from the inward migration of part of the outer neuroblastic layer to 
join the mullerian cells of the inner neuroblastic layer (23). The remaining portion of the 
outer neuroblastic layer will later develop into the photoreceptor cell bodies. The end of 
retinal maturation (except for the development of the fovea) is marked by the formation 
of the vascular system in the internal retina at eight months (23). 
Only a few of the factors that control retinal proliferation are understood. 
Proliferation appears to be both stimulatory and inhibitory. Transforming growth factor-
a, acidic and basic fibroblast growth factors, and epidermal growth factors stimulate the 
proliferation of retinal progenitor cells in cultures (20,23). The growth factors regulate 
the cell proliferation through intracellular signaling cascades that ultimately influence the 
cell-cycle control system (20). Also neurotransmitter systems may inhibit or at least 
regulate proliferation. 
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The Macula and Fovea 
The development of the macula is rapid during the first three months of fetal life 
but then lags behind the rest of the retina until after the eighth month of gestation. The 
macula is not fully developed until 16 to 18 weeks after birth. The macula first develops 
as a localized increase in the superimposed nuclei in the ganglion cell layer, lateral to the 
optic disc ( 16). During the seventh month of gestation there is a peripheral displacement 
of the ganglion cells, leaving a central depression, which is known as the fovea (16). 
The Vitreous Humour 
The vitreous body makes up approximately 80% of the volume of the eye and is 
formed in three stages. The primary vitreous, a highly vascularized gel, develops in the 
fourth to sixth weeks of gestation (12). In the early stages as the optic cup grows, the 
space formed is filled by this vascularized gel which is a combination of primary fibrillar 
material secreted from the embryonic retina and secondary fibrillar material apparently 
secreted from the cell walls of the hyaloid artery after its penetration into the space (24). 
The primary vitreous atrophies and is replaced by the avascular secondary vitreous, which 
develops after the sixth week of gestation (24). 
The secondary vitreous is associated with the vitreous space increasing in size and 
the regression of the hyaloid vascular system ( 12). This regression is not immediate but 
after some time all that is remaining is a tube of primary vitreous surrounded by 
secondary vitreous running from the retrolental space to the optic nerve (24). 
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The tertiary vitreous develops in the fourth month of gestation. This tertiary 
vitreous also known as the zonules is the fibrillary material that suspends the lens within 
the eye. During childhood the vitreous undergoes significant growth (24). 
The Optic Nerve 
The optic nerve forms from the optic vesicle which is originally connected to the 
forebrain by a short tube called the optic stalk (25). Primitive blood vessels and glial 
cells form a cone-shaped zone, known as the Bergrneister papilla, on the surface of the 
developing optic disk. These vessels and glial cells later atrophy, producing the 
physiologic optic cup of the disk ( 12). 
At six weeks of gestation, axons from the retinal ganglion cells form the nerve 
fiber layer as they converge from all parts of the retina toward the optic disk and first 
enter the optic stalk. As the nerve fibers from different regions of the retina continue 
joining, the nerve fiber layer becomes thick near the optic disc ( 12). Around the ninth 
week of gestation these retinal ganglion cell axons first reach the dorsal nucleus of the 
lateral geniculate body, where they form small bundles and develop the central 
connections. By the eleventh week the optic chiasm is formed, which originates from 
these optic nerve fibers as they cross each other. Later in life, uncrossed fibers enter the 
optic chiasm, producing the adult configuration (12,25). Around the fifth month of 
gestation myelination of the optic nerve begins in the region of the geniculate bodies and 
reaches the globe by about the eighth month. Myelination of the optic fibers is usually 
complete by one month after birth ( 12,25). 
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The Sclera 
The sclera first appears during the embryonic period, where it is formed by 
mesenchymal cells that condense around the optic cup (14). These mesenchymal cells 
differentiate into the tough, protective sclera after they receive inductive signals from the 
embryonic retinal pigment epithelium. The sclera forms first anteriorly at the limbus near 
the future insertion of the rectus muscles and then grows posteriorly (18). 
The Choroid 
The choroid develops from two embryonic tissues, the mesoderm and cranial 
neural crest cells (26). Inductive signals from the embryonic retinal pigment epithelium 
play a role in the formation of the choroid (18). Blood vessels first appear in the choroid 
during the 15th week of development, and arteries and veins can be recognized by the 
22nd week. 
Chronological Development 
The eye is sophisticated organ, with a complex developmental pathway. Table 1 
outlines a summary of the chronological development of the human eye, with 
developmental milestones and associated gestational ages. 
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Table 1. The following table identifies the chronological development of the human 
eye, with developmental milestones and associated gestational age. Table 
created by Deepak P. Edward, and Lawrence M. Kaufman (12). 
Chronological development of the eye 
Gestational Age Developmental Milestone 
22 days - Optic primordia appears 
2nd month - Hyaloid artery fills embryonic fissure 
- Closure of embryonic fissure begins 
- Lid folds appear 
-Neural crest cells (corneal endothelium) migrate centrally; 
corneal stroma follows 
- Choroidal vasculature starts to develop 
- Axons from ganglion cells migrate to optic nerve 
3rd month - Sclera condenses 
- Lid folds meet and fuse 
4th month - Retinal vessels grow into nerve fiber layer near optic disc 
- Schlemm's canal appears 
- Glands and cilia develop in lids 
5th month - Photoreceptors develop inner segments 
- Lids begin to separate 
6th month - Dilator muscle of iris forms 
7th month - Central fovea thins 
- Fibrous lamina cribrosa forms 
- Choroidal melanocytes produce pigment 
8th month - Iris sphincter develops 
- Chamber angle completes formation 
- Hyaloid vessels regress 
- Retinal vessels reach periphery 
- Myelination of optic nerve fibers is complete to lamina cribrosa 
-Pupillary membrane disappears 
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v. Hereditary Eye Disease 
Hereditary eye disease can be defined as the transmission of gene defects or 
chromosomal aberrations/abnormalities which produce extreme variation in the structure 
or function of the eye. These may be evident at birth, or may become manifest later as 
the disorder progresses. 
The pace of gene identification of the causes of inherited eye diseases has 
increased substantially over the past decades with the use of new technologies and the 
creation of the Human Genome Project databases. The contribution of ocular genetics to 
human gene discovery has been exceptional, beginning with a strong interest in ocular 
genetics by clinical ophthalmologists and ocular geneticists alike who have carefully 
described the patterns of inheritance of familial eye disorders (27,28). Families readily 
participate in research to understand the nature of their disorders with the hope that 
visions aids may be provided or that new treatments might be found to prevent such 
disorders. Patients with inherited eye disorders and their families have complex needs, 
which include clinical services for diagnosis and management and social and genetic 
counseling to help them cope with the conditions (27). A specific clinical and genetic 
diagnosis provides the patient and family with a framework for discussions on prognosis, 
treatment, and the heritability of a condition (28). 
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In Newfoundland and Labrador the following hereditary disorders affecting parts 
of the eye have been identified as a cause of genetic blindness: 
Retina: 
Retinitis Pigrnentosa (RP), Cone Dystrophy, Cone-Rod Dystrophy, 
Newfoundland Rod-Cone Dystrophy (NFRCD), Achromatopsia, Leber 
Congenital Amaurosis (LCA), Juvenile Macular Dystrophy (Stargardt Disease), 
Bardet-Biedl Syndrome (BBS), Usher Syndrome. 
Anterior Segment: 
Aniridia, Corneal Dystrophy, Cataracts. 
Optic Nerve: 
Optic Atrophy, Leber Hereditary Optic Neuropathy (LHON). 
Others: 
Ocular Albinism, Oculocutaneous Albinism, Microphthalmia, Coloboma, 
Anophthalmia, Myopia, Retinoblastoma, Glaucoma. 
A review of previous Newfoundland studies of inherited eye diseases is provided in 
Appendix B. 
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Retinitis Pigmentosa 
Retinitis Pigmentosa (RP) is a heterogeneous group of retinal degenerations in 
which abnormalities of the photoreceptors (rods and cones) or the retinal pigment 
epithelium (RPE) of the retina lead to progressive visual loss. Affected individuals first 
experience defective dark adaptation or night blindness, followed by constriction of the 
peripheral visual field and, eventually, loss of central vision late in the course of the 
disease (28,29). 
The genetics of RP is complex, where the disorder can be inherited in an 
autosomal dominant, autosomal recessive, or X-linked manner. Autosomal dominant RP 
(adRP) accounts for 15%-20% of all RP cases and is characterized by significant allelic 
and non-allelic heterogeneity, 20%-25% are autosomal recessive (arRP), l 0%-15% are X-
linked (XLRP), and the remaining 40%-55% are simplex (28,30). Simplex cases are 
individuals with RP with no known family history so the mode of inheritance is not 
known. It may be arRP, adRP caused by a new mutation, and if male, may be XLRP. 
Many genes for RP have been identified or mapped to a particular chromosomal region 
including: 19 loci, with 18 identified genes for adRP, 26 loci, with 23 identified genes for 
arRP, and 6 loci, with 2 identified genes for XLRP (31). 
New loci and genes are being identified rapidly for RP and other retinal disorders 
as more molecular research projects are completed. Figure 10 reveals the extent of the 
advances made in identifying new genes causing retinal disease over the past two 
decades. 
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Figure I 0. Mapped and Identified Retinal Disease Genes 1980-2012 was reproduced 
from RetNet: Summaries of Genes and Loci Causing Retinal Diseases (31). 
Cone Dystrophy 
Cone dystrophy is an ocular disorder characterized by the progressive dysfunction 
of cone cells, which are light-sensitive retinal photoreceptors responsible for both sharp 
central visual acuity and color vision/discrimination (32). The most common symptoms 
of cone dystrophy include reduced visual acuity, sensitivity to bright lights, and poor 
color vision (33). Individuals with cone dystrophy have normal vision initially and then 
develop a progressive abnormality of the cones. There is considerable clinical and 
genetic heterogeneity; cone dystrophies showing autosomal dominant, autosomal 
recessive, and X linked recessive inheritance have all been reported. X-linked cone 
dystrophies, CODl and COD2 have been mapped to Xp11 .4 and Xq27 respectively 
(34,35). COD3, involving the gene GUCAIA, was mapped to 6p2 1.1 (36). 
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Cone Rod Dystrophy 
Cone rod dystrophies (CRDs) are retinal dystrophies that can be classified as 
pigmentary retinopathies. They are characterized by retinal pigment deposits visible on 
fundus examination, predominantly localized to the macular region. CRD is 
characterized by primary cone involvement or sometimes by loss ofboth cone and rod 
function that explains the predominant symptoms of the dystrophies which are: decreased 
central visual acuity, color vision defects, and photo sensitivity, later followed by 
progressive loss in peripheral vision and night blindness (37). CRDs are most frequently 
non syndromic, but they may also be part of other syndromes, such as Bardet-Biedl 
syndrome (3 7). 
Non syndromic CRDs are genetically heterogeneous with ten cloned genes and 
three other loci being identified so far (37). Four major causative genes involved in the 
pathogenesis ofCRDs are ABCA 4 (38), CRX (39) , GUCY2D (40), and RPGR (41). 
Newfoundland Rod-Cone Dystrophy 
Newfoundland Rod-Cone Dystrophy (NFRCD) is a retinal dystrophy found in a 
particular region of Newfoundland. Initially reminiscent of retinitis punctata albescens, it 
is an autosomal recessive, progressive rod-cone dystrophy that is characterized by night 
blindness and white stippling throughout the fundus ( 42), but NFRCD has a substantially 
earlier age at onset, more-rapid progression, and a distinctive sequence of retinal changes 
resulting in an atrophic retina (43). Symptoms such as night blindness are evident during 
infancy, followed by the progressive loss of peripheral, central, and colour vision during 
childhood. Severe loss of vision is seen by the 2nd to 4th decade of life ( 43). Molecular 
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analysis showed linkage to markers on the long arm of chromosome 15, in a region 
encompassing RLBP 1, a gene encoding the cellular retinaldehyde-binding protein, and 
confirmation as being the causative gene was established (43). RLBPI was initially 
identified as a candidate gene for the Newfoundland population because a retinal 
dystrophy with similar retinal appearance had been identified in an extended family in 
Bothnia (Northern Sweden) and homozygous mutations in RLBP I were identified 
(44,45,46). 
A chromatopsia 
Achromatopsia also known as rod monochromacy or total congenital color 
blindness is a rare autosomal recessive retinal disorder. This disorder is characterized by 
a total absence of the ability to discriminate colors, severely reduced visual acuity, 
sensitivity to light, and nystagmus observed soon after birth (33). The disorder is usually 
diagnosed during early infancy and does not progress after childhood ( 4 7). However, the 
majority of individuals with achromatopsia are registered blind. 
Achromatopsia can be further divided into a complete and an incomplete form. 
Symptoms of complete achromatopsia are strongly reduced visual acuity, complete 
absence of the ability to color discriminate, extreme light sensitivity, and nystagmus. The 
incomplete form is characterized by a milder phenotype with residual color vision and 
less severely reduced visual acuity (33 ,47). 
Three causative genes involved with achromatopsia have been identified 
including: CNGA3 located at 2q 11 , which encodes the cone cyclic nucleotide-gated cation 
channel alpha subunit ( 48), CNGB3 located at 8q21, which encodes the cone cyclic 
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nucleotide-gated cation channel beta subunit (49), and GNAT2 located at 1pl3, which 
encodes the cone photoreceptor-specific alpha-subunit oftransducin, a G protein of the 
phototransduction cascade (50), 
Leber Congenital Amaurosis 
Leber congenital amaurosis (LCA) is a group of retinal dystrophies that are 
recognized at birth or very early in life. An infant presents with severely reduced vision, 
nystagmus, and poor pupillary reaction (32,51). Associated with LCA is a highly variable 
appearance of the retina, ranging from a normal appearance to a retinitis pigmentosa like 
picture (51). Many of the children develop a characteristic eye poking behavior. 
Hypermetropia and keratoconus frequently develop over the course of the disease as well 
(28). 
The transmission of LCA is usually as an autosomal recessive trait, and rarely as 
an autosomal dominant trait. Ten loci and seven genes involved with LCA have been 
identified including: GUCY2D mapped to 17p 13.1 (52), CRBJ mapped to l q31 (53), 
RP£65 mapped to lp31 (54), RPGRJPJ mapped to 14ql1 (55) ,AJPLJ mapped to 17p 13 .1 
(56), TULP 1 mapped to 6p21.3 (57), CRX mapped to l9q 13.3 (58), and three other loci 
without identified genes, LCA3 on chromosome 14q24 (59), LCA5 on chromosome 6q 11-
q 16 ( 60), and LCA9 on chromosome I p36 ( 61 ). 
Macular Dystrophy 
Hereditary juvenile macular dystrophies comprise a heterogeneous group of 
degenerative diseases of the retinal macula characterized by central visual loss due to 
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atrophy of the macula and underlying retinal pigment epithelium (32,62,63). Dystrophies 
showing autosomal dominant, autosomal recessive, X linked recessive and mitochondrial 
inheritance have all been reported (32,62,63). Several genes involved with juvenile 
macular dystrophy have been identified including: VMD2 mapped to ll q l3 (64,65), 
EFEMPJ mapped to 2pl6 (66), RDS mapped to 6p21.2 (67,68), MCDRJ mapped to 
6ql4-ql6.2 (69), TIMP3 mapped to 22ql2.2-ql3.2 (70) and ABCA4 mapped to l p22 
(71 , 72). Stargardt disease is the most common juvenile hereditary macular degeneration. 
Age-related macular degeneration (ARMD) is the most common cause of severe 
vision loss in people over 50 years of age in developed countries (73,74). Predisposition 
to ARMD includes age, environmental factors, and some genetic factors. ARMD is a 
degenerative disorder ofthe macula that results in loss of central vision (73,74). 
Stargardt Disease 
Stargardt disease affects the central retina (macula) and is one of the most 
common autosomal recessive retinal dystrophies with an estimated incidence of one in 
10,000 (7 5). The disease is also the leading cause of juvenile macular degeneration and 
central vision loss. Later symptoms include loss of color vision, sensitivity to light, 
central scotoma and slow dark adaptation (28). Onset may occur as young as 7-12 years 
of age, or possibly in the teens or twenties, with the bilateral loss of central vision 
following over a several month to several year period (32). Depigmentation and atrophy 
of the macular retinal pigmentary epithelium is usually seen along with yellowish flecks 
surrounding the macula (76). 
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The gene for Stargardt disease was mapped to chromosome lp22 in 1993 (71) and 
in 1997 mutations were identified in the ABCA4 gene, encoding an ATP-binding cassette 
transporter (72). The ABCA4 gene is expressed in rod and cone photoreceptors (77). 
Bardet-Biedl Syndrome 
Bardet-Biedl syndrome (BBS) is a rare, autosomal recessive disease characterized 
by retinal dystrophy, renal structural abnormalities, obesity, dysmorphic extremities, and 
hypogenitalism (78,79,80). BBS is genetically heterogeneous, caused by autosomal 
recessive inheritance, with at least 12 different genes identified: BBSJ (l1ql3), BBS2 
(16q2l), BBS3 (3p 12-q 13), BBS4 (l5q23), BBS5 (2q31), BBS6 (20p 12), BBS7 ( 4q32), 
BBS8 (l4q31), BBS9 (7p14.3), BBSJO (12q21.2), BBSJJ (9q3l-34.1), and BBS/2 (4q27) 
(81,82,83,84,85,86,87,88,89,90,91,92,93,94) 
To fit the definition of having BBS a person must show at least four of the 
cardinal features listed above or three cardinal manifestations in a sibling of an affected 
person with four cardinal features (80). The current prevalence of BBS in Newfoundland 
is approximately l in 18,000 which is significantly higher than other populations around 
the world (79,80,84,95). 
Usher Syndrome 
The Usher syndromes are a genetically and clinically heterogeneous group of 
autosomal recessive conditions named after Charles Usher. These syndromes are 
characterized by congenital or early onset sensorineural hearing loss accompanied by a 
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retinal dystrophy indistinguishable from retinitis pigmentosa (96). The Usher syndromes 
are considered the most common of the syndromic retinal dystrophies (20). 
The Usher syndromes are subdivided on the basis ofthe severity of auditory and 
vestibular dysfunction. Three patterns have been recognized: 
I). Usher syndrome type I is characterized by congenital and severe to profound hearing 
impairment with vestibular dysfunction. The ability to speak rarely develops and visual 
symptoms are apparent by ten years of age (20,96). Six Usher syndrome type I loci have 
been mapped to chromosomes. USHlA maps to l4q32 (97), lB maps to 1lql3.5 (98), 
lC maps to 11p15.1 (99), lD maps to 10q21-q22 (100), lE maps to 21q2l (101) and, 1F 
maps to 10q2l-22 (102). 
2). Usher syndrome type II is characterized by early moderate to severe hearing loss and 
normal vestibular function. Speech may develop and visual symptoms are apparent by 
the late teens (20,96). Three Usher syndrome type II loci have been mapped to 
chromosomes. USH 2A maps to lq41 (99), 2B maps to 3p24.2-p23 (103), 2C maps to 
5q 14-q21 ( 1 04). 
3). Usher syndrome type III is rare and characterized by adult onset progressive hearing 
loss associated with variable vestibular function (20,96). One Usher syndrome type III 
locus has been mapped to chromosome 3q21-q25 (1 05). 
Aniridia 
Aniridia is a rare congenital condition characterized by the underdevelopment of 
the iris, usually occurring in both eyes. It is associated with poor development of the 
retina at the back of the eye preventing normal vision development. The most 
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characteristic morphological feature of the iris in aniridia is a total loss of iris tissue, 
however partial and irregular loss of iris tissue may be seen ( 1 06). 
The degree of visual impairment is quite variable from person to person (27). The 
iris may appear normal with only mild hypoplasia, or the iris may consist of a 
rudimentary stump of tissue of variable size. In some cases, this remnant can be seen on 
external examination, whereas in other cases it can be seen only by examining the eye. 
[n most cases, aniridia is inherited in an autosomal dominant fashion with almost 
complete penetrance but variable expressivity. One third of cases of aniridia are sporadic, 
most often because of a new mutation. Genetic analysis of most families with aniridia 
has identified a causative mutation in the PAX6 gene, which is located on chromosome 
band 11 p 13. P AX6 is a paired box transcription factor that is one of the master control 
genes involved in regulating eye development (1 07). This gene is still a candidate gene 
for the families in Newfoundland, with molecular studies being completed in the future 
which would identify specific mutations. 
Corneal Dystrophy 
Corneal dystrophies are a group of hereditary disorders, characterized by a non-
inflammatory, bilateral opacity of the cornea (1 08,1 09). They commonly appear as 
grayish white lines, circles, or clouding of the cornea and may not significantly affect 
vision in the early stages. These disorders are commonly subdivided according to the 
layer of the cornea affected by the dystrophy. They are generally inherited in an 
autosomal dominant fashion with variable penetrance and expressivity ( 108, 1 09). There 
has been several important genes discovered dealing with the corneal dystrophies. 
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Missense mutations seen in the BIGH3 gene, located on chromosome 5q31 , which is 
highly expressed in the corneal epithelium, causes mutations in the Transforming Growth 
Factor Beta Induced protein (TGFBI). These mutations of BJGH3 were identified in 
families affected with several types of corneal dystrophies including: granular, Reis-
Bucklers, lattice type I, and Avellino ( 11 0). Other genes, including, KRT3 (chromosome 
12q 13) and KRT12 (chromosome 17ql2) involved with Keratin 3 and 12 proteins 
respectively, are specifically found in the corneal epithelium and responsible for Juvenile 
epithelial corneal dystrophy or Meesmann dystrophy (111, 112). 
Cataracts 
A cataract is a clouding or any opacification that develops in the crystalline lens of 
the eye. Cataracts vary in degree from slight to complete opacity and may obstruct the 
passage of light (28, 113 ). Cataracts can be defined by the age at onset: a congenital or 
infantile cataract presents within the first year of life; a juvenile cataract presents within 
the first decade of life; a presenile cataract presents before the age of about 45 years, and 
senile or age-related cataract after that (113). 
Congenital cataracts are particularly serious because of the potential for inhibiting 
visual development, resulting in permanent blindness (28, 11 3). Hereditary cataracts 
represent a major contribution to congenital and juvenile cataracts. Hereditary cataracts 
are most frequently inherited as autosomal dominant traits, but also can be inherited in an 
autosomal recessive, or X-linked fashion (11 3). Currently, about 39 genetic loci 
responsible for hereditary cataracts have been mapped and numerous genes identified. 
Genes involved with autosomal dominant cataracts include: CRYBBJ, CRYBB2, CRYGC, 
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CRYGD, CRYAA, CRYAB, CRYBAJ, MAF, BFSP2, HSF4, MJP, CX46, CX50, and PITX3. 
The genes involved with autosomal recessive cataracts are LIM2 and CRYAA. X-linked 
inherited cataracts have an association with the CXN gene (114,115,116,11 7). 
Optic Atrophy 
Optic atrophy is the result of atrophy of extensive amounts of optic nerve fibers 
(118, 119, 120). Two broad types of optic atrophy exist: acquired and congenital. 
The acquired (non-hereditary) type of optic atrophy may be a result of several 
separate causes such as: (a) blood supply changes in the eye or optic nerve, (b) 
inflammation or swelling within the optic nerve (optic neuritis), (c) a pressure against the 
optic nerve, such as from a tumour, or (d) metabolic diseases (diabetes mellitus), trauma, 
glaucoma, or toxicity (118,119,120). 
If congenital, it is usually hereditary with deterioration starting in childhood. It 
may be accompanied by nystagmus. Autosomal recessive optic atrophy is a relatively 
rare entity, noticed occasionally in an infant and therefore termed congenital, but it is 
more frequently discovered around 3 to 4 years of age (118, 120). Autosomal dominant 
optic atrophy or Kjer's optic neuropathy usually presents in early childhood (11 8, 120). 
Responsible for Kjer's optic neuropathy is the OPAl gene which was mapped to 
chromosome 3q28-q29 from linkage analysis of three Danish families ( 121 ). 
Alternatively, non-hereditary congenital optic atrophy can be caused by a lack of oxygen 
during pregnancy, labour or in the early days of a child's life. 
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Leber Hereditary Optic Neuropathy 
Leber hereditary optic neuropathy (LHON) is a mitochondrial inherited 
degeneration of retinal ganglion cells and their axons. Clinically, there is an acute onset 
of visual loss, first in one eye, and then a few weeks to months later in the other. This 
commonly evolves to very severe optic atrophy and permanent decrease of central visual 
acuity but in some individuals there is recovery of central vision. LHON is more 
common in males than females and often presents in the teens or twenties. LHON is due 
to a mutation of the mitochondrial genome and hence is passed exclusively through the 
mothers (28, 122, 123). 
LHON is usually due to one of three pathogenic mitochondrial DNA (mtDNA) 
point mutations, occurring at nucleotide positions 11778 (G to A), 3460 (G to A) and 
14484 (T to C), respectively in the ND4, NDJ and ND6 subunit genes of complex I of the 
oxidative phosphorylation chain in mitochondria (122, 123). 
Albinism 
Albinism is the term used to describe a heterogeneous group of inherited disorders 
characterized by eye and skin hypopigmentation, and ocular abnonnalities such as 
reduced visual acuity and nystagmus (28). Two broad types of albinism exist. 
Oculocutaneous albinism (OCA) involves two regions of the body: the skin and hair, and 
the optic system including the eye and the optic nerves. It is an autosomal recessive 
disease with several known genes. OCA Type I is caused by mutations in the tyrosinase 
gene (TYR) and maps to chromosome 11q14-2 1 (124). OCA Type II involves the human 
homologue, P gene, which maps to chromosome l5q11.2-ql2 (125,126). OCA Type III 
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is caused by a tyrosinase-related protein (TYRP-1) , encoded by the B gene, mapped to 
chromosome 9p23 (127). OCA Type IV is caused by a mutations in the human 
orthologue ofunderwhite that encodes a membrane associated transporter protein mapped 
to chromosome 5p ( 128). 
Ocular albinism (OA) involves similar changes in the visual system with reduced 
pigment in the retinal pigment epithelium of the eye, however it does not affect the 
normal pigment of the skin or hair. OA is an X-linked disease with one gene identified, 
OAJ, mapped to chromosome Xp22.3, which has been linked to defective glycosylation 
and thus improper intracellular transportation (129, 130). 
Microphthalmia 
Microphthalmia is a disorder in which one or both of the eyes are abnormally 
small. It may be designated as simple, where it is observed without other ocular disease; 
or complex, where it is associated with cataracts, aniridia, retinal dysplasia, vitreous 
disease or other malfonnations (28). Microphthalmia can be further divided into 
colobomatous and non-colobomatous categories (28, 131 ). 
In simple microphthalmia one or both of the eyes are reduced to two-thirds of 
their normal volume without any other ocular abnormality except hypermetropia and 
occasionally aplasia of the macula. Complex microphthalmia also shows a reduction in 
the overall size of the eyes. It is possible that microphthalmia is secondary to associated 
malformations rather than merely accompanied by them (131 ). 
Microphthalmia can be isolated, sporadic, or familial with several types of 
transmission such as autosomal dominant, autosomal recessive, and X-linked recessive 
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( 13 1 ). Of monogenic causes, the genes SOX2, P AX6, OTX2, RAX, CHXJ 0, FOXE3, and 
CRYBA are associated with mutations linked to microphthalmia, however only SOX2 has 
to date been identified as a major causative gene for microphthalmia ( 132). SOX2 has 
been mapped to a locus at 3q26.3 ( 132, 133). 
Coloboma 
Colobomas are defects or simply "holes" in the structures of the eye, including the 
lens, iris, choroid or optic disc. The "hole" is present from birth and can be caused when 
a gap between two structures in the eye called the choroid fissure which is present early in 
development in the uterus, fails to close completely before a child is born. Ocular 
colobomas are frequently seen in association with other developmental defects such as 
microphthalmia. A coloboma can occur in one or both eyes (131 , 134). The gene CHD7 
mapped to chromosome 8q 12 has been reported to be associated with colobomas along 
with several other malformations (135). 
Anophthalmia 
In true anophthalmia, there is complete failure of primary optic vesicle outgrowth, 
or the optic vesicle has completely degenerated ( 131 , 136). Clinical anophthalmia is the 
apparent absence of the globe in an orbit that otherwise contains normal associated 
structures (13 1,136). As with microphthalmia, only the SOX2 (mapped to 3q26.3) gene 
has been identified as a major causative gene for anophthalmia (132, 133). 
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Myopia 
Myopia or nearsightedness is a focusing defect in which the focal point is in front 
of the retina. People with myopia may see nearby objects clearly but distant objects 
appear blurred. With myopia, the eyeball is too long, or the cornea is too steep, so images 
are focused in the vitreous inside the eye rather than on the retina at the back of the eye. 
The common way to correct myopia is through the use of corrective lenses, such as 
glasses or contact lenses. It may also be corrected by refractive surgery. In high myopia, 
it is not possible to correct the vision defect with lenses or surgery. The majority of 
myopia is not caused by a single gene disorder. However there are cases of myopia, 
typically high myopia, which show simple Mendelian inheritance patterns of autosomal 
dominant, autosomal recessive, or X-linked (13 7). At least 17 myopia loci (MYP 1 -17) 
have been mapped (28). 
Retinoblastoma 
Retinoblastoma (RB) is an embryonic neoplasm which originates in the primitive 
retinal cells. These cells undergo malignant transformation before their final 
differentiation. Although it is the most common intraocular malignant tumor seen in 
infancy and childhood, it is relatively rare with an estimated incidence between 1 in 
15,000 to 1 in 20,000 live births (28, 138). RB seldom arises after 3 or 4 years of age due 
to the disappearance of the primitive retinal cells within the first few years of life. The 
prevalence of RB among populations around the world is remarkably constant, where it is 
shown not to have a significant racial distribution and it affects both sexes equally. This 
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strongly implies that environmental factors play very little role in the etiology of the 
tumor (21, 139). 
In 1987, researchers found the RB 1 gene, and identified its protein product, which 
linked the cancer to control of the cell cycle (140). RBI is a large tumor-suppressor gene, 
on chromosome 13q 14, and involves 27 exons (8, 135). The involved protein (known as 
Prb) normally binds transcription factors so that they cannot activate genes that carry out 
mitosis. It normally halts the cell cycle at the G 1 phase. When the RBI gene is mutant or 
missing, the hold on the transcription factor is released, and cell division ensues, leading 
to the formation of cancers (8,28). 
About half of the infants who develop RB inherit susceptibility to the disorder, 
where they have one germline mutant allele for the RBI gene, inherited in an autosomal 
dominant manner, in each of their cells (8,28). Cancer develops in any somatic cell where 
the second copy of the RB gene mutates or is lost. Therefore, inherited RB requires two 
point mutations or deletions, one germline and one somatic (8). In sporadic (non-
inherited) cases, two somatic mutations occur in the RBI gene. The study of RB was the 
origin of Knudson's "two-hit" hypothesis of cancer causation, which states that two 
mutations (gennline and somatic or two somatic) are required to cause a cancer related to 
tumor suppressor deletion or malfunction (141). Inheritance of the predisposition to RB is 
an autosomal dominant trait (138). 
RB expands from its originating location to fi ll the eye and even extending as far 
as the optic nerve, orbit, sinuses, and brain (138). In developed countries the survival rate 
is close to 90% due to medical care being readily available, where the tumour can be 
detected early and removed by a surgical procedure. 
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Glaucoma 
Glaucoma is characterized by increased intraocular pressure resulting in damage 
to the optic nerve and retinal nerve fibers (142). It is associated with a heterogeneous 
group of disorders. It is a common cause of preventable vision loss that may be treated 
by prescription drugs or surgery, with the majority of cases being age-related. Hereditary 
glaucoma can be divided into two types: primary open-angle glaucoma (POAG) and 
primary congenital glaucoma (PCG). 
Hereditary primary open-angle glaucoma (POAG) is a severe disease that appears 
early in life and results in high intraocular pressure and optic nerve damage. [tis often 
inherited in an autosomal dominant manner (28, 142, 143). Stone et al mapped a gene for 
primary congenital glaucoma, MYOC, to chromosome 1q21-23 (144). 
Primary congenital (PCG) or infantile glaucoma occurs at birth or early childhood, 
usually within the first year of life, but may develop later up to three years of age (28,29). 
It is characterized by increased intraocular pressure, corneal edema, enlargement of the 
globe, and a sensitivity to light, and is mainly inherited as an autosomal recessive disorder 
(28, 142, 145). A gene for primary congenital glaucoma, GLC3A, was mapped to 
chromosome 2p21 by Sarfarazi et al in 1995 (146). 
Molecular genetics is an ever expanding field of research, with many new loci and 
genes being identified rapidly for all inherited eye diseases in laboratories around the 
world. This research has the potential to revolutionize the diagnosis and treatment of 
inherited eye diseases. 
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VI. RESEARCH OBJECTIVES 
In 1981 a cohort of I ,013 prevalent cases of blindness, registered with the CNIB, 
was studied (147, 148). Established monogenic disease was the cause of blindness in 24% 
of cases and presumed in a further 6%. Since that original study, considerable new 
clinical information and family history data has been accumulated. In addition, incident 
cases with various causes of inherited blindness have been identified. The molecular 
genetic cause of several conditions including: Bardet-Biedl Syndrome, Newfoundland 
Rod-Cone Dystrophy, Peters Anomaly, and X-linked Ocular Albinism have been 
determined. The research objectives of this thesis are: 
I. To determine the number of cases of eye disease attributable to monogenic disease 
following long term follow up and to compare this to the original results reported 
immediately following inception of the cohort in 1981. 
2. To identify the blindness phenotypes observed in each geographical region of the 
provmce. 
3. To determine whether geographic clustering of specific phenotypes occurred. 
4. To determine whether mutation specific disease clustered in particular geographic 
regions. 
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VII. HYPOTHESES 
1. That long term follow-up of the 1981 cohort would identify a higher proportion of 
eye disease being attributable to monogenic disease than originally reported. 
2. That multiple different causes of blindness would be observed in each geographic 
region and that causes of monogenic blindness would differ from region to region. 
3. That rare diseases and mutation specific diseases would cluster in specific 
geographic areas, consistent with the idea that Newfoundland comprises multiple 
genetic isolates. 
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VIII. SUBJECTS AND METHODS 
The records of the Canadian National Institute of the Blind (CNIB) were reviewed 
by Dr. Jane Green in 1982/83. One thousand and thirteen patients in NL, registered as 
blind with The Canadian National Institute of the Blind (C 18) on December 31, 1981, 
were studied. For registration in Canada a person must satisfy one of the following 
criteria; (a) visual acuity of20/200 (6/60) or less in the better eye with best correction 
possible or (b) a total visual field of less than 10° from fixation with a white target 1 Omm 
in diameter at I m ( 14 7). The records of each registrant were reviewed in detail in 1982/3 
to determine the diagnosis and the cause of visual loss, as well as the ancestral location of 
the family. 
Individual blind registrants were categorized by anatomical location of disease 
and by geographical origins. The coding used by the CNIB was adapted from the 
classification of the National Society for the Prevention of Blindness. There are separate 
codes for diagnosis (site and type oflesion) and for etiology (147). Two of the codes for 
etiology denote probable or possible hereditary eye disease. Where there was some 
ambiguity in the diagnosis or etiology, every attempt was made to arrive at the precise 
diagnosis, by Dr. Jane Green, through examining the person, by writing to other 
ophthalmologists within or outside the province or by researching the ancestral pedigree. 
Many registered individuals as well as other family members were seen at regular 
ocular genetics clinics in St. John ' s or at outreach clinics at various locations around the 
province since 1980. Follow up appointments for further investigations such as visual 
field testing, colour vision testing, dark adaptation testing and electrophysiological 
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(electroretinogram and electrooculogram) procedures were completed. The 
electroretinogram (ERG) procedure tests a person's sensitivity to differing colours and 
intensities of light in scotopic (dark background) or photopic (light background) 
conditions including scotopic blue, red, and white, photopic white, and photopic flicker. 
The ERG is used to measure the electrical responses of the light-sensitive photoreceptor 
cells, the rods and cones. A dim blue light tests rod function whereas bright white light or 
flickering light tests cone function. The electrooculogram (EOG) procedure measures the 
resting potential of the retina. The EOG is used to assess the function of the pigment 
epithelium as well as recording eye movements. Unlike the ERG, the EOG does not 
represent the response to individual visual stimuli. 
In 2007/8 the 1,0 13 cases in the 1981 cohort were reviewed again, by Dr. Jane 
Green and I, including clinic visit notes, and reports of visual field, color vision, dark 
adaption, electroretinogram, and electro-oculogram testing over the intervening years. 
Family histories for many individuals were updated from 1982 to 2006, and available 
molecular genetic results obtained. Diagnoses were revised as necessary based on new 
information, and ongoing studies. The cause of blindness was determined based on this 
updated information, and I stratified them according to anatomic location and specific 
diagnosis. Diagnoses made in 1982/3 (148) were compared to those now made in 2007/8. 
During the period from 1982/3 to 2007/8 extended studies to identify the 
molecular genetic cause of certain diseases have been undertaken, in which new incident 
cases to the Ocular Genetics clinic, provincial ophthalmologists and Provincial Medical 
Genetics Program were included with the prevalent cases in the 1981 cohort. Molecular 
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genetic studies were performed in Bardet-Biedl Syndrome (26 families) (79), 
Newfoundland Rod Cone Dystrophy (six families) (43), and X- linked ocular albinism 
(two families) (129, 149). 
Family histories were updated for all those who had a molecular genetic cause of 
their disease identified, and classified according to the molecular genetic diagnosis. 
Families with potential for novel gene discovery were identified. 
A timeline representation of the Newfoundland Cohort from creation to its current 
day use for novel gene discovery is as follows: 
1981 Cohort 
1983 diagnosis 
2007 diagnosis 
Monogenic Other 
1 1 
Molecular diagnosis Potential for novel gene discovery 
The database with infonnation pertaining to all 1,013 individuals was revised 
using the computer program SPSS, over the first year of my project, with help from Dr. 
Jane Green. The information included is: name, date of birth, date of registration, age at 
registration, sex, CNIB #,geographical location of ancestors, maiden name (where 
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applicable), site type code, etiological code, hereditary classification (genetic/non-
genetic), original CNIB diagnosis from 1980, revised diagnosis from 1982/3, revised 
diagnosis from 2007/8, extra notes pertaining to each diagnosis, and information on other 
identified family members. The cohort consisted of 551 male and 462 female individuals, 
with an average age of 52 years when the cohort was created in 1981. 
The geographic location of the ancestral home of each proband and geographic 
distribution of each disease was mapped. Much time was spent, by Dr. Green, over 
several years trying to contact the families involved and reviewing family records to trace 
the ancestors back to their originating communities and I constructed geographic maps 
showing these locations. After completion, the distribution of disease in each geographic 
coastal area was observed to identify if any clustering of diseases had occurred or if a 
random occurrence was displayed. 
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IX. RESULTS 
Monogenic causes of blindness in The 1981 Cohort 
In Newfoundland in 1981 the prevalence ofblindness was 1.8 per 1,000 people 
(1,013 registered blind in a population of 567,681). The causes of blindness among the 
people within the Newfoundland cohort as diagnosed initially in 1981 and following 
review in 2007/8 are summarized in Table 2. Ofthe 1,013 cases reviewed in 2007/8, 305 
(30%) were found to have an established genetic monogenic disease and a further 123 
( 12%) have a presumed monogenic disease. This is an increase from the initial diagnosis 
where it was reported that 243 (24%) of cases had established and 56 (6%) had presumed 
monogenic genetic disease. Most changes in diagnosis occurred in people classified as 
congenital cataract and multiple anomalies, myopia, vascular/systemic disease, or other. 
The specific causes of the established genetic diseases (N = 305) are presented in 
Table 3 according to anatomical location of the diseases. Fifty percent (N = 152) had 
Retinal disease, 17% (N = 51) Albinism, 11 % (N = 3 5) Anterior segment disorders, 4% 
(N = 11) Congenital abnormalities of the whole eye, 3% (N = 10) Optic nerve disease, 
and 15% (N = 46) other genetic disorders. 
Among the 152 patients with retinal disease 25% (N = 38) had Retinitis 
Pigmentosa, 20% (N = 31) had Bardet-Biedl syndrome, 13% (N = 20) had Stargardt 
disease, and 9% (N = 14) had Achromatopsia. Among the 51 patients with Albinism 53% 
(N = 27) had X-linked Ocular Albinism and 47% (N = 24) had Oculocutaneous Albinism. 
The groups with Anterior segment disease, Optic nerve disease, Congenital abnormalities, 
and other genetic disorders comprised multiple different disorders. The causes of 
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Table 2. Causes of blindness among the persons in Newfoundland, determined after 
27 years follow-up, compared to initial diagnosis made in 1981. 
Classification (year) 
Cause of Blindness 1981 2008 
Number of o;o Number of 
Persons Persons 
Genetic Established 243 24.0 305 
Genetic Presumed 56 5.5 123 
Congenital : cataract and multiple anomalies 110 10.9 78 
High myopia 100 9.9 61 
Infectious disease 88 8.7 90 
Trauma 67 6.6 68 
Age related macular degeneration (ARMD) 60 5.9 63 
Diabetic retinopathy 59 5.8 61 
Glaucoma 48 4.7 46 
Vascular or other systemic disease 41 4.0 17 
Age related cataract 34 3.4 39 
Tumour 22 2.2 18 
Other 61 6.0 31 
Undetermined 24 2.4 13 
Total 1,013 100 1,013 
The data from 198 1 was reproduced from the following reference: 
Green JS, Johnson OJ. Hereditary diseases as causes of blindness in Newfoundland: 
preliminary report. Canadian journal of ophthalmology. 18( 6): 28 1-4, 1983 . 
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0/o 
30.1 
12.1 
7.7 
6.0 
8.9 
6.7 
6.2 
6.0 
4.5 
1.7 
3.9 
1.8 
3. 1 
1.3 
100 
Table 3. The causes of blindness in 2008 by anatomical location and specific 
hereditary disease among the persons in whom a genetic cause was 
t bl" h d ~ ll l t f ll es a IS e o owmg ong erm o ow-up. 
Number Number 
Genetic Cause Mfected Affected 
(Individuals) (Families) 
Established (total) n =305 11 = 192 
Retina n = 152 n = 103 
Retinitis Pigmentosa (RP) 38 30 
Bardet-Biedl Syndrome (BBS) 31 17 
Stargardt Disease 20 12 
Achromatopsia 14 7 
Newfoundland Rod-Cone Dystrophy (NFRCD) 8 6 
Rod-Cone Dystrophy (RCD) 6 5 
Usher Syndrome 7 5 
Cone, Cone-Rod Dystrophy 2 2 
Leber Congenital Amaurosis (LCA) I l 
Retinal Dystrophy (Unspecified) 14 II 
Macular Dystrophy (Unspecified) II 7 
Anterior Segment n = 35 n = 22 
Cataract (Hereditary, Congenital, and Juvenile) 17 \0 
Aniridia 7 4 
Comeal Dystrophy 6 5 
Anterior Segment (Unspecified) 5 3 
Albinism n = 51 11 = 17 
Ocular Albinism 27 2 
Oculocutaneous Albinism 24 15 
Optic Nerve 11 = 10 n = 7 
Optic Atrophy 8 5 
Leber Hereditary Optic Neuropathy (LHON) 2 2 
Congenital Abnormalities 11 = 11 n = 7 
Microphthalmia I Dwarfism 4 2 
Microphthalmia 2 2 
Coloboma 4 3 
Anophthalmos I I 
Other 11 = 46 n = 35 
Myopia 16 8 
Retinoblastoma 5 5 
Nystagmus 5 5 
Glaucoma (Congenital) ,.., ,.., <.. <.. 
Other Genetic 18 15 
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Percentage of 
Total Affected 
(Individuals) 
100 
49.9 
12.4 
10.2 
6.6 
4.6 
2.6 
2 
2.3 
0.7 
0.3 
4.6 
3.6 
11.5 
5.6 
2.3 
2 
1.6 
16.7 
8.8 
7.9 
3.3 
2.6 
0.7 
3.6 
1.3 
0.7 
1.3 
0.3 
15 
5.2 
1.6 
1.6 
0.7 
5.9 
presumed genetic diseases are presented in Table 4, with the most frequent being 
Microphthalmia (N = 25), Myopia (N = 24), and Coloboma (N = 23). A total of284 
cases were re-diagnosed between the years 198 1 and 2008. There was a substantial 
increase in the diagnosis of established genetic disease (N = 62), and of presumed genetic 
disease (N = 67). 
Geographical Distribution of monogenic disorders 
Figure 1 (page 4) shows the population distribution around the coastline of 
Newfoundland. Table 5 summarizes the geographic location of the ancestral home of 
families with the various inherited eye disorders identified. This includes families from 
the prevalent 1981 cohort and incident cases identified since that time. 
Conception Bay is an area of early settlement starting in 1610. It has a relatively 
high population density (N = 51 ,639) but, despite its proximity to the urban population in 
and around St. John's (N = 125,266) (Figure 1), individual small communities were 
relatively isolated at the time of initial assessment in 198 1. Within this geographic area 
multiple different phenotypes have been observed. The most frequent inherited causes of 
blindness identified include (i) Retinitis Pigmentosa, (ii) Bardet-Biedl Syndrome, (i ii) 
Stargardt Disease, and (iv) Newfoundland Rod Cone Dystrophy. Individual cases of 
Usher Syndrome, Achromatopsia, Oculocutaneous Albinism, and Congenital Cataracts 
also occur. In addition to this diversity of disease, a branch of a family with X-linked 
ocular albinism had moved from the North East Coast to Conception Bay. 
This diversity of inherited eye disease is observed in each geographic area, for 
example in Notre Dame Bay on the North East Coast (N = 54,542), 12 different 
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Table 4. The causes of blindness in 2008 by anatomical location and specific 
hereditary disease among the persons in whom a genetic cause was 
presumed following long term follow-up. 
Genetic Cause Number Affected Percentaee Affected 
Possible (total) n = 123 100 
Retina n = 9 ,, :;. 7.3 
Retinal Dystrophy (Unspecified) 8 6.5 
Macular Dystrophy (Unspecified) I 0.8 
' Anterior Segment 
' 
n=8 6.5 
Cataract 5 4. 1 
Anterior Segment (Unspecified) 2 1.6 
Corneal Dystrophy 1 0.8 
Optic Nerve o I< n=7 
:F 
5.7 ,, 
Optic Atrophy 7 5.7 
Congenital Abnormalities 
,, 
n ::; 53 " 43.1 
'" 
, 
Microphthalmia 25 20.3 
Coloboma 23 18.7 
Anophthalmos 5 4. 1 
Other n = 46 "··' . ''· 37.4 
Myopia 24 19.5 
Nystagmus 7 5.7 
G laucoma (Congenital and Juvenile) 5 4 .1 
High Hyperopia I 0.8 
Other Retina 7 5.7 
Other Congenital 2 1.6 
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Table 5: Distribution of families* with monogenic eye diseases by geographic region 
of ancestral home. 
St. Concepti South Burin South South Bay of N01them N01th Bona vi 
John 's on Bay Avalon Pen ins Coast West Islands Peninsula East sta Bay 
ula Coast Coast 
Population 125266 51639 25602 30368 26209 27749 22562 25758 54542 28589 
( 1981) 
Retinitis 2 16 9 12 2 I 2 4 6 9 
Pigmentosa 
Bardet Biedl 4 6 I I 2 3 I I 2 I 
Syndrome 
Stargardt 2 13 I I - - I - 2 I 
Usher I I 4 I - 2 - - 3 -
Achromatopsia - 3 - I - I - - I -
Nlld Rod Cone - 6 - - - - - - - -
Dystrophy 
Cone - - I - - - - - - -
Dystrophy 
Ocular - - - - I - - - I -
Albinism 
Oculocutaneous - I I I - I I 2 2 -
Albinism 
Leber's -LHON - - - - 2 - - - - -
Peters Anomaly - - I - - - - - - -
Congenital - I - - I - - - I -
Cataracts 
Co meal - - - I - - - - 4 -
Dystrophy 
Ani1idia I - - I - - - - I I 
Anterior - - - - - 2 - - I -
Segment 
disorder 
Microphthalmia - - - I 2 - - - - -
Dwarfism 
High Myopia - - - - - - I I I I 
retinal 
detachment 
Retinoblastoma 2 I I I 
TOTAL 12 47 19 20 II 10 6 8 26 13 
TOTAL/ 0.96 9. 10 7.42 6.59 4.20 3.60 2.66 3. 11 4 .77 4 .55 
10,000 
*Prevalent families identified in 1981 through review of CNIB records, and incident 
families identified thereafter. 
T1inity 
Bay 
32069 
4 
4 
I 
3 
-
-
-
-
3 
-
-
-
-
-
-
-
-
15 
4 .58 
Note. Five families located in Labrador were not included in the table due to infonnation 
on population not being available. 
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Total 
67 
26 
22 
15 
6 
6 
I 
2 
12 
2 
I 
3 
5 
4 
3 
3 
4 
5 
187 
-
monogenic diseases causing blindness were identified (Table 5). Furthermore the 
distribution of these conditions differs by area with some diseases occurring only in 
one area e.g. Leber hereditary optic neuropathy and Microphthalmia Dwarfism, both rare 
conditions, were observed only on the South Coast. 
Mutations Detected in five disorders, with geographic distribution 
During the period from 1982/3 to 2007/8 extended studies have been undertaken 
to identify the molecular genetic cause of certain ocular diseases including: Bardet-Biedl 
Syndrome, Newfoundland Rod-Cone Dystrophy, X-linked Ocular Albinism, Stargardt 
Disease, and Peters Anomaly. Each study included patients identified in the original 
cohort and also incident patients identified since 1981 . Table 6 presents the identified 
mutations and genes pertaining to these ocular disorders within the province. 
Bardet-Biedl Syndrome 
Thirty one patients (1 0%) of the 1981 cohort, from 17 different families, had 
Bardet-Biedl Syndrome (BBS). Eight ofthese families contained multiple individuals. 
By 2007 BBS was identified in 46 cases, from 26 families (Figure ll ). DNA was 
obtained from members of 21 families, and the molecular genetic cause of the disease 
was identified in all of these families (Table 7). Nine mutations in six BBS genes were 
identified. 
Some clustering of these mutations was seen. Four BBSJ families homozygous 
for the M390R mutation clustered along the Southwest Coast. All families with the 
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Table 6. Identified genes and mutations in Bardet-Biedl Syndrome, Newfoundland 
Rod-Cone Dystrophy, Stargardt Disease, Peters Anomaly, and X-linked 
Ocular Albinism. 
Cohort Extended r Map 
Genetic Ocular Condition Study Study Gene(s) Location References 
N N 
Retina 
Bardet-Biedl Syndrome (BBS) 31 46 
M390R homozygous 8 BBS I llql 3 79, 84 
Y24X homozygous I BBS2 16q21 79, 84 
G l69A homozygous 5 BBS3 3p l3-p l2 79, 84 
IVS6+3A>G homozygous 5 BBS5 2q3 1 79, 84 
Dl43fsX157 homozygous; F94fsX 103 homozygous; 15 BBS6 20pl 2 79, 84 Dl43fsX157 I F94fsX103; F94fsXI 03 I L277P 
C9 1 fsX95 homozygous; 
"FI 98 del, Fl99 del" I C9 lfsX95 6 BBS I O 12q2 1.2 79, 84 
Unknown (No DNA) 6 
,. 
Newfoundland Rod-Cone Dystrophy (NFRCD):?' < 8 26 RLBPI I'Sq26 43 
(324G>A) homozygous 
(IVS3+2 T>C) homozygous 
(324G>A) I (IVS3+2 T>C) compound heterozygote 
Stargardt Disease 20 37 ABCA4 l p22 
Molecular studies in process 
Anterior Segment 
Peters Anomaly 
' 
0 I I FOXE3 150 
c.959G>T heterozygous (AD) 
Albinism 
Ocular Albinism 27 30 
X-linked (IVS7-2 A>T) 30 OA I Xp22.3 129, 149 
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Figure 11. Pedigrees ofNewfoundland Bardet-Biedl syndrome patients. 
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This figure was reproduced from the following reference: 
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NF-B8 
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NF-B26 
Moore SJ, Green JS, Fan Y, Bhogal AK, Dicks E, Fernandez BA, Stefanell i M, Murphy 
C, Cramer BC, Dean JC, Beales PL, Katsanis N, Bassett AS, Davidson WS, Parfrey PS. 
Clinical and genetic epidemiology ofBardet-Biedl syndrome in Newfoundland: a 22-year 
prospective, population-based, cohort study. American Journal of Medical Genetics. 
132(4): 352-60, 2005. 
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Table 7: Genotypes in Bardet-Biedl Syndrome Families in Newfoundland. 
Mutation (Combinations) BBS Families Cases 
88S 1: M390R Homozygous 87, 88, 810, 815, 819, 823 8 
88S2: Y24X Homozygous 814 1 
88S3: G169A Homozygous 82 5 
88S5: IVS6+3A----+G Homozygous 89 5 
88S6: D143fsX157 Homozygous 813, 820 4 
88S6: F94fsX103 Homozygous 83, 84, 816, B25 8 
B8S6: D143fsX157 I F94fsX103 81 2 
88S6: F94fsX103 / L227P 85 1 
88S 10: C91 fsX95 Homozygous 812, 8 21 2 
BBS10: F198 del, Fl99 del / C9lfsX95 86, 811 4 
Unknown I No DNA 817, 81 8, 8 22, 8 24, 8 26 6 
Total 26 46 
The data was reproduced from the following reference: 
Webb M, Dicks EL, Green J, MooreS, Warden G, Gamberg J, Davidson WS, Young T, 
Parfrey PS. Autosomal recessive 8 ardet-8iedl syndrome: first-degree relatives have no 
predisposition to metabolic and renal disorders. Kidney International. 76(2): 215-23, 
2009. 
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F94fsX103 mutation whether homozygous or compound heterozygous were originally 
from Conception Bay. However cases from two BBSJ 0 families, homozygous for the 
C91 fsx95 mutation, were from communities geographically distant from each other 
(Connaigre Peninsula and Green Bay). BBS2, BBS3 and BBS5 mutations were each seen 
in only one nuclear or extended family in a homozygous state, each in a separate genetic 
isolate. Individuals who were compound heterozygotes for BBS6 and BBSJO mutations 
occurred in several communities indicating the wide spread nature of the mutations 
(Figure 12). 
Newfoundland Rod-Cone Dystrophy 
Eight patients (3%) ofthe 1981 cohort in 6 different families had Newfoundland 
Rod-Cone Dystrophy (NFRCD). At the time of an extended study during the 1990's, 
NFRCD had been identified in 26 patients from six families , all with ancestors from one 
specific region in Conception Bay (Figure 13). Fifteen of the subjects came from one 
extended pedigree and each of the other five families had 2-3 affected individuals 
(Figure 14) (43). Two splice junction mutations in the RLBPJ gene on the long arm of 
chromosome 15 were identified. In the large pedigree, cases were identified who were 
homozygous for the 324G~A mutation, homozygous for the IVS3+2 T ~c mutation, or 
compound heterozygous for the two mutations. Individuals in three smaller families from 
the same region were homozygous for IVS3+2 T ~c, and affected individuals in two 
families were compound heterozygous with both the 324G~A and IVS3+2 T ~c 
mutations (Table 8). 
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Figure 12: The Geographic Distribution (Ancestral Locations) of Bardet-Biedl Syndrome 
mutations in Newfoundland. 
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BBS6 
e Dl43fsXI57 Homozygous 
Q F94fsX I 03 Homozygous 
Dl43fsXI57 I F94fsX103 
F94fsX103 I L227P 
BBSlO 
e C9 1 fsX95 Homozygous 
F 198 del, F 199 del!C91 fsX95 
St. John's 
Figure 13: The Geographic Distribution (Ancestral Location) of Newfoundland Rod-Cone Dystrophy 
in Newfoundland. 
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e Newfoundland Rod-Cone Dystrophy (NFRCD) 
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St. John's 
Figure 14. Pedigrees of 6 Newfoundland families diagnosed with Newfoundland 
Rod- Cone Dystrophy (NFRCD). 
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Mutation and haplotype data for six Newfoundland pedigrees diagnosed with NFRCD. 
All individuals were genotyped for D15S205 and D15S127 and were sequenced for 
RLBP 1. Haplotypes were then constructed for D15S205-SpliceMutl-SpliceMut2-
D15S127, with polymorphic alleles expressed in terms of base pairs. SpliceMutl = 
324G---+A; SpliceMut2 = IVS3+2 T ---+C. Each colored bar represents a unique haplotype: 
yellow = 135-324G---+A-wt-142; blue = 124-324G---+A-wt-134; red = 159-wt-IVS3+2 
T ---+C-136; green = 135-wt- IVS3+2 T ---+C-140; gray= non-disease-associated 
haplotypes. 
The data was reproduced from the following reference: 
Eichers ER, Green JS, Stockton DW, Jackman CS, Whelan J, McNamara JA, Johnson 
GJ, Lupski JR, Katsanis N. Newfoundland rod-cone dystrophy, an early-onset retinal 
dystrophy, is caused by splice-junction mutations in RLBP 1. American Journal of Human 
Genetics. 70(4): 955-64, 2002. 
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Table 8: Two Splice-Junction Mutations in RLBPJ cause Newfoundland Rod Cone 
Dystrophy. 
Family Mutation Inheritance 
NF-001 324G-+A Homozygous 
IVS3+2 T-+C Homozygous 
324G-+A I lVS3+2 T -+C Compound heterozygote 
NF-003, 324G-+A Homozygous 
NF-004, 
NF-006 
NF-005, 324G-+A I IVS3+2 T -+C Compound heterozygote 
NF-008 
The data was reproduced from the following reference: 
Eichers ER, Green JS, Stockton OW, Jackman CS, Whelan J, McNamara JA, Johnson 
GJ, Lupski JR, Katsanis N. Newfoundland rod-cone dystrophy, an early-onset retinal 
dystrophy, is caused by splice-junction mutations in RLBP 1. American Journal of Human 
Genetics. 70( 4): 955-64, 2002. 
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Albinism 
Ocular Albinism (X-linked) was reported in a large Newfoundland kindred in 
1971 and linkage to markers from Xp 22.3 was demonstrated in 1993 ( 149). The 
mutation in the OAJ gene was identified as IVS7-2 A>T in 2005, through clinical studies 
in Ontario and was provided to the Provincial Medical Genetics Program. In the original 
report in 1971 ( 149) a pedigree of 6 generations was traced back to an individual who 
lived in Morton's Harbour, New World Island around 1840. The people with the disease 
were well known in the outports as having "dancing eyes". Twenty seven males with 
ocular albinism from this large family were originally examined. Descendants of these 
individuals have now spread out across Newfoundland from the original focus area 
(Figure 15). A second large kindred with ocular albinism was identified on the South 
Coast, and the Notre Dame Bay OAI mutation was excluded. This clinical work was 
conducted by Dr. Jane Green, and efforts to identify the specific mutation are ongoing 
(Figure 15). 
Stargardt Disease 
Thirty three families with Stargardt Disease were identified in Newfoundland, all 
with autosomal recessive disease. DNA was obtained from members of22 fami lies, 
including 37 affected and 25 unaffected family members. Ancestors from 13/22 (59%) 
families came from the Conception Bay area and ancestors of other families came from a 
number of different regions, particularly in the north east or south east part of the island 
(Figure 16). The gene for Stargardt Disease was mapped to chromosome 1p in 1993 (71 ) 
and the ABCA 4 gene was identified as the gene for autosomal recessive Stargardt Disease 
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Figure 15: The Geographic Distribution of Ocular Albinism (OA) in Newfoundland. 
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Figure 16: The Geographic Distribution (Ancestral Locations) ofStargardt Disease in 22 
Newfoundland families, from whom DNA was obtained. 
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St. John's 
St. Mary's Bay 
in a previous study in 1997 (72). ABCA4 is a very large gene, with 50 exons. Sequencing 
of all 50 exons is underway to identify the specific mutations causing Stargardt Disease in 
the identified Newfoundland families. Since all identified families in Newfoundland have 
autosomal recessive disease, from pedigree analysis, the ABCA4 gene is the only one 
being sequenced. 
Autosomal Dominant Peters Anomaly 
Members of a large family having a variable ocular phenotype ranging from 
microcornea to Peters Anomaly, segregating as an autosomal dominant trait, are from 
Placentia Bay (Figure 17). A molecular genetics project was recently completed 
to determine the molecular etiology of the variable anterior segment dysgenesis (ASD) in 
this family. Researchers sequenced nine candidate genes and identified 44 variants. A 
point mutation in FOXE3, which codes for a transcription factor involved in the formation 
of the lens and surrounding structures, co-segregated with the variable ocular phenotype. 
This novel mutation (c.959G>T) substitutes the stop codon for a leucine residue, 
predicting the addition of 72 amino acids to the C-terminus of FOXE3 (150). 
Geographic distribution of other monogenic disorders 
Retinal Disorders 
As the genetics of retinal dystrophies is complex, the approach taken to determine 
the genetic basis of retinal dystrophies has been to investigate subgroups with similar 
phenotypes. Consequently initial work has been undertaken in fami lies with Bardet-Biedl 
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Figure 17: The Geographic Distribution (Ancestral Locations) of Anterior Segment Disorders in 
Newfoundland. 
Windsor 
aux Basques 
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Syndrome, Newfoundland Rod-Cone Dystrophy, and Stargardt Disease. Retinitis 
Pigmentosa (RP) occurs frequently in Newfoundland, in locations all across the province 
(Figure 18). The inheritance pattern for RP may be autosomal dominant (AD), autosomal 
recessive (AR) or X-linked recessive. In Newfoundland, a total of 67 families with RP 
have been identified, with 37 having known inheritance patterns, including one large 
family with X-linked inheritance, eight families with autosomal dominant inheritance, 11 
families with autosomal recessive inheritance, and 17 simplex cases (possible ARora 
new mutation AD or X-linked). 
Usher Syndrome has been identified in 15 families, from several areas in the 
province with no particular clustering (Figure 19). Specific mutations are not currently 
known, however a molecular genetics project is being developed to determine the specific 
mutation(s) involved. 
Achromatopsia (with a congenital cone dysfunction causing decreased central 
vision and absent colour vision) is a rare autosomal recessive retinal disorder, which 
showed random geographic distribution of seven families. Families with affected 
individuals were from Conception Bay, Fortune Bay, St. George's Bay, and Notre Dame 
Bay (Figure 20), which is consistent with autosomal recessive disease likely caused by 
multiple different mutations. The genes CNGA3, CNGB3, and GNA T2 have been 
identified as possible Achromatopsia genes, and molecular studies are ongoing to identify 
specific mutations. 
Cone dystrophy, an autosomal recessive disease, was identified in one family 
from the Southern A val on Peninsula (Figure 21 ). 
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Figure 18: The Geographic Distribution (Ancestral Locations) of Retinitis Pigmentosa in 
Newfoundland. 
• 
• 
Corner Brook 
Channel Port 
aux Basques 
• • 
- 71 -
e Retinitis Pigmentosa 
Notre Dame Bay 
Bonavista Bay 
Trinity Bay 
Conception Bay 
St. John's 
Figure 19: The Geographic Distribution (Ancestral Locations) ofUsher Syndrome in 
Newfoundland. 
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Figure 20: The Geographic Distribution (Ancestral Locations) of Achromatopsia in Newfoundland. 
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Figure 21: The Geographic Distribution (Ancestral Locations) of Rare Genetic and Ophthalmic 
Disorders in Newfoundland. 
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Anterior Segment Disorders 
Several anterior segment disorders were identified including Aniridia, Congenital 
and Juvenile Cataracts, Corneal Dystrophy, and Peters Anomaly/Microcornea/Cataracts. 
Four families with Corneal Dystrophy clustered in Notre Dame Bay and a fifth in Fortune 
Bay were identified. No clustering was identified for any other of these rare disorders 
(Figure 17). Four families with Congenital Cataracts were from various locations 
including: the South Coast, Notre Dame Bay, A val on Peninsula, and the South Coast of 
Labrador. Three additional families , unrelated to each other, with other anterior segment 
disorders, are located in the Notre Dame Bay and St. George's Bay area's (Figure 17). 
Oculocutaneous Albinism 
Oculocutaneous Albinism was identified in 15 families, with clusters of affected 
individuals in Trinity Bay, White Bay, and on the Northern Peninsula and several other 
distinct families (Figure 22). 
Optic Nerve 
Leber hereditary optic neuropathy, a mitochondrial disease, was identified in two 
families located on the South Coast of the province (Figure 21 ). 
Other Eye Disorders 
Microphthalmia Dwarfism was identified in 4 individuals, from 3 families, which 
have been connected in an extended pedigree, are from the South Coast of Newfoundland 
(Figure 21 ). A gene discovery project is currently underway. 
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Figure 22: The Geographic Distribution (Ancestral Locations) of Oculocutaneous Albinism 
(OCA) in Newfoundland. 
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St. John's 
Families with autosomal recessive or autosomal dominant inheritance for High 
Myopia/Retinal Detachment, have been identified from St. George's Bay, Northern 
Peninsula, Notre Dame Bay, and Bona vista Bay (Figure 21 ). 
Retinoblastoma was identified in five families, three from the Avalon Peninsula, 
and two others in Grand Falls-Windsor and Bay D'Espoir respectively (Figure 23). A 
specific mutation causing Retinoblastoma has been identified in the largest family. Other 
mutations are yet to be identified, however linkage to the RB 1 gene has been confirmed. 
Newfoundland Population in 1981 and the Present Day Clustering of Disease 
[n 1981 the population of the province was 567,68 1, of which only 17 4,521 (31 %) 
lived in towns or cities of over 10,000 people (N= 4) (Figure l , page 4). The majority 
lived in small communities of less than 2,000 people, distributed around the coast of 
Newfoundland (3). The map (Figure l , page 4) shows the population distribution in these 
small communities by coastal region (N=368,217; 65%). Only 24,916 (4.4%) people 
lived in the interior of the province (communities of Gander and Grand Falls-Windsor). 
Geographical maps indicating the locations of some inherited eye disease within 
Newfoundland and Labrador are provided in Figures 12, 13, and 15-23 . These 
geographical maps indicate that inherited eye disease is widespread throughout the 
province, yet some specific eye diseases are concentrated in certain small regions. The 
study indicates the widespread distribution of some hereditary eye disorders and the 
occurrence of some rare conditions in specific isolated populations including: Ocular 
Albinism within the New World [sland area, and Newfoundland Rod-Cone Dystrophy 
within Conception Bay. 
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Figure 23. The Geographic Distribution (Ancestral Locations) of Retinoblastoma in Newfoundland. 
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Within the Conception Bay area multiple different causes of blindness have been 
observed including: (i) Retinitis Pigmentosa; (ii) Bardet-Biedl Syndrome caused by three 
different mutations in BBS6 and by two mutations in BBSJ O; (iii) Newfoundland Rod-
Cone Dystrophy caused by two different mutations in the RLBP 1 gene; (iv) Stargardt 
Disease; (v) Achromatopsia; (vi) Usher Syndrome; (vii) X-linked Ocular Albinism as a 
branch of the Notre Dame Bay family; (viii) Oculocutaneous Albinism; and (ix) 
Congenital Cataracts. 
Around the coast of the Southern Avalon the causes of blindness include: (i) 
Retinitis Pigmentosa; (ii) Bardet-Biedl Syndrome caused by mutations in BBSJ; (iii) 
Stargardt Disease; (iv) Cone Dystrophy; (v) Autosomal dominant Peters Anomaly/Micro-
Cornea/Cataracts; (vi) Aniridia; and (vii) Oculocutaneous Albinism. 
On the Burin Peninsula the cause of blindness included: (i) Retinitis Pigmentosa; 
(ii) Stargardt Disease; (iii) Achromatopsia; (iv) Oculocutaneous Albinism; (v) Aniridia; 
and (vi) Corneal Dystrophy. 
Along the South Coast the causes ofblindness include: (i) Retinitis Pigmentosa; 
(ii) Bardet-Biedl Syndrome caused by mutations in BBSJ and BBSJO; (iii) Ocular 
Albinism; (iv) Congenital Cataracts; (v) Leber Hereditary Optic Neuropathy; and (vi) 
Microphthalmia Dwarfism. 
On the South West Coast of the province causes of blindness included: (i) 
Retinitis Pigmentosa; (ii) Bardet-Biedl Syndrome caused by mutations in BBSJ and 
BBS6; (iii) Achromatopsia; (iv) Usher Syndrome; (v) Oculocutaneous Albinism; and (vi) 
Anterior Segment Disease. 
- 79-
The causes ofblindness in The Bay oflslands on the West Coast included: (i) 
Retinitis Pigmentosa; (ii) Bardet-Biedl Syndrome caused by a mutation in BBSJ; (iii) 
Stargardt Disease; (iv) Oculocutaneous Albinism; and (v) High Myopia/Retinal 
Detachment. 
On the Northern Peninsula of the Island the causes of blindness included: (i) 
Retinitis Pigmentosa; (ii) Bardet-Biedl Syndrome; (iii) Oculocutaneous Albinism; and 
(iv) High Myopia/Retinal Detachment. 
On the North East Coast of the Island the causes ofblindness included: (i) 
Retinitis Pigmentosa; (ii) Bardet-Biedl Syndrome caused by mutations in BBS5 or BBSJ 0; 
(iii) Stargardt Disease; (iv) Achromatopsia; (v) Usher Syndrome; (vi) X-linked Ocular 
Albinism; (vii) Oculocutaneous Albinism; (viii) Congenital Cataracts; (ix) Corneal 
Dystrophy; (x) Anterior Segment Disease; and (xi) High Myopia/Retinal Detachment. 
In Bonavista Bay the causes of blindness include: (i) Retinitis Pigmentosa; (ii) 
Bardet-Biedl Syndrome caused by a mutation in BBSJ ; (iii) Stargardt Disease; (iv) 
Aniridia; and (v) High Myopia/Retinal Detachment. 
In Trinity Bay the causes ofblindness include: (i) Retinitis Pigmentosa; (ii) 
Bardet-Biedl Syndrome caused by mutations in BBS2 or BBSJO; (iii) Stargardt Disease; 
(iv) Usher Syndrome; and (v) Oculocutaneous Albinism. 
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X. DISCUSSION 
Newfoundland and Labrador is peopled by a young founder population, which in 
1981 had a high prevalence of blindness resulting from established and presumed 
monogenic disease. The long follow-up (27 years) of this population-based cohort has 
not only revealed the multiplicity of inherited diseases causing blindness, but facilitated 
the examination of the genetic complexity associated with similar phenotypes. The 
relatively small population of the province, derived from founders from small areas of 
England and Ireland, consists of not just one genetic isolate but multiple isolates, each 
with its own genetic architecture, which has predisposed to various inherited eye diseases. 
These genetic isolates today represent an important source of informative families for 
identifying genes for inherited disorders. The important features associated with some of 
these families are the existence of multigenerational and extended pedigrees mostly 
descended from a small number of founders about 8-10 generations ago. An example is 
provided in Figure 24. 
Cohort follow-up: Comparing 1981 to 2008 
Ofthe 1,013 cases reviewed in 2007/8,305 (30%) individuals were found to have 
an established genetic disease and a further 123 (12%) have a presumed genetic disease. 
This shows a 6% increase in the number of people within each of these genetic categories 
since the initial review was completed. The majority of changes in diagnosis occurred in 
people classified as congenital cataract and multiple anomalies, myopia, 
vascular/systemic disease, or other. This substantial increase in the number diagnosed 
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Figure 24. Extended multigenerational pedigree of a Newfoundland family with 
Ocular Albinism. 
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Pedigree was reproduced with consent from Dr. Jane Green, Professor of Genetics, 
Memorial University of Newfoundland. 
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with established genetic disease and with presumed genetic disease following long term 
follow up, is less surprising when one considers: ( 1) the availability of serial clinic notes 
and investigations over many years, (2) the enhancement of family history that occurs 
through multiple meetings with families, (3) the focus on making a molecular genetic 
diagnosis in several conditions. 
The term "presumed genetic disease" was used when an individual was suspected 
to have a strong genetic component, on the basis of family history, to their disease. This 
was the case for individuals who were unable to be seen by Dr. Green, were unwilling to 
provide samples of DNA, or due to death. The category of established genetic disease 
therefore, could be, and most likely is underestimated within the Newfoundland 
population. 
The study that was closest in scale to the current study was completed by Odland 
in 1981 (15 1 ), who tried to ascertain all the blind and partially sighted persons in Bergen, 
Norway and the surrounding county of Hordaland. Odland concluded that in terms of the 
isolation of communities that county did not differ from the rest of the country, and 
therefore the prevalence and causes of blindness in that county could be considered 
representative of those for the whole country. Thirty percent were j udged to have an 
established hereditary or presumed hereditary eye disease, which shows a slightly lower 
proportion than this current revised study, but a very similar proportion to the initial 
results reported from this current study in 1981 ( 14 7). One must suspect that the 
prevalence of genetic eye disease as a cause of blindness in Norway was underestimated, 
as was the prevalence in Newfoundland, and research in Norway would benefit from a 
long term follow up to more accurately diagnose genetic disease. 
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Around the world a high proportion of childhood blindness is due to hereditary 
disease. Genetically determined conditions accounted for 77% of childhood blindness in 
Lebanon (152), 79% in Cyprus (ofwhich halfwere autosomal recessive disorders) (153), 
84% and 89% in Saudi Arabia as reported in 2 separate studies (154, 155). [n 13 countries 
of Africa, Latin America and Asia, examined between 1990-1994, genetic disease was the 
cause of blindness in 39% of cases, with autosomal recessive inheritance being reported 
in 22-52% of cases ( 156). 
An appropriate comparison between this Newfoundland Cohort study and other 
hereditary eye disease studies could not be completed due to the lack of comparable 
studies in the literature. This is one shortcoming of this current paper seeing that a 
comparison with respect to the number of people affected in each etiological category of 
disease within Newfoundland cannot be compared to other populations. 
Newfoundland: The ideal population for identifying the genetic basis of disease. 
The Newfoundland population has facilitated the elucidation of the genetic basis 
of many diseases. The current study of blindness arising from the 1981 cohort has 
facilitated the identification of several genes causing hereditary eye disease particularly: 
Bardet-Biedl Syndrome. The molecular genetic basis ofNewfoundland Rod Cone 
Dystrophy, and X-linked Ocular Albinism was also determined. Studies examining the 
molecular genetic basis ofblindness in Retinitis Pigmentosa, Achromatopsia, Stargardt 
Disease, Microphthalmia Dwarfism and other Anterior Segment Disorders are now 
underway in Newfoundland. New studies examining the molecular genetic basis of other 
types of hereditary blindness may follow. 
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Another shortcoming of this current study is the fact that there are very few 
molecular genetic confirmations of the clinical diagnoses of the people involved (Bardet-
Biedl Syndrome, Newfoundland Rod Cone Dystrophy, X-linked Ocular Albinism and 
Peters Anomaly/Microcornea/Cataracts being the exceptions). However molecular 
genetic studies of Stargardt Disease, Achromatopsia and Retinitis Pigmentosa are 
underway. Even with this shortcoming, this current project has paved the way for future 
comparison studies within the Newfoundland population to be undertaken following the 
completion of current molecular genetic studies. 
Newfoundland is an ideal place for identifying the genetic basis of eye disease in 
that it has a young founder population, consisting of multiple genetic isolates, where the 
original immigration of these isolates has predisposed to the frequent occurrence of 
blindness caused by multiple different mutations in different genes. The genetic 
architecture of the Newfoundland population has facilitated the identification of novel 
genes. Accurate phenotypic description of cases within families and determination of 
inheritance patterns, with geographic mapping of families, may facilitate the 
identification of novel genes and mutations in various diseases causing blindness in 
Newfoundland. 
Along with the geographic isolation, the Newfoundland population demonstrates a 
high degree of cultural and environmental homogeneity ( 4). The benefit of such founder 
populations over heterogeneous populations to identify genes for rare monogenic 
disorders is unquestioned. Genetic isolates, in which founder alleles were driven to a 
high frequency due to restriction of gene flow in the population, still persist today in 
various Newfoundland outports. Although little immigration has occurred in many of 
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these communities during the last two centuries, improvements in transportation and 
significant out-migration from the Newfoundland outports, will start to change the 
demographics of these geographic isolates. Consequently, now is the opportune time to 
determine the molecular genetic basis of blindness. Our population based study has 
identified families with multiple genetic diseases causing blindness within multiple 
genetic isolates of Newfoundland to be characterized by collaboration with molecular 
geneticists to examine the DNA of family members. 
Geographic distribution of disease 
Some inherited diseases are distributed throughout the various regions of the 
province with some clustering observed. There are several isolated regions in which 
specific disorders are seen. Leber hereditary optic neuropathy and Microphthalmia 
Dwarfism, both rare conditions, were observed only on the South Coast of the province. 
Two different mutations occurred in an extended pedigree with Newfoundland Rod Cone 
Dystrophy living in Conception Bay, leading to homozygous inheritance of different 
mutations in two sibships and to compound heterozygote in a third sibship. The diversity 
of disease is not surprising given the complex structure of the eye, dependent on the 
normal function of multiple different genes. It is hypothesized that within these clusters, 
mutation specific diseases will be found, and that across regions, multiple different 
mutations will be identified as the cause of the same disorder. 
This is the case for Bardet-Biedl Syndrome where there are mutations in 6 BBS 
genes in various communities around the province but there are specific isolates with 
some of these mutations in a homozygous state such as BBSJ (on the Southwest Coast), 
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BBS6 (in Conception Bay), BBS3 (in North Avalon), and BBS5 (in White Bay). Other 
families with BBS caused by compound heterozygote mutations in BBS6 and BBSJ 0 have 
been identified in diverse areas around the coast. The distribution of BBS mutations in 
Newfoundland demonstrates that the province is not one genetic isolate, but consists of 
multiple isolates. 
Examination of the geographic distribution of other autosomal recessive diseases 
(Stargardt Disease, Usher Syndrome, Achromatopsia, and Oculocutaneous Albinism) 
reveals similarities to the distribution of Bardet-Biedl Syndrome, some clustering but also 
random distribution around the coast of the island. This suggests that multiple different 
mutations will be identified as causes for these diseases. It also suggests that for novel 
gene discovery investigation of families grouped by geographic area may be helpful. 
The elucidation of the genetic basis of Retinitis Pigmentosa may be more 
complex, particularly as the disease may result from autosomal dominant, autosomal 
recessive or X-linked inheritance. However in Newfoundland clustering of Retinitis 
Pigmentosa occurs, particularly in Conception Bay, on the Burin Peninsula, and in 
Bonavista Bay. Nonetheless families with the disorder occur in every geographic area 
around the coast, as expected based on the substantial genetic heterogeneity of this 
disorder with over 50 genetic loci for RP having been identified (3 1 ). 
Although new mutations occur frequently, there is no need to assume an increased 
mutation rate to explain the finding of multiple mutations causing specific diseases in 
Newfoundland. The high prevalence of blindness and the high frequency of genetic 
disease as a cause ofblindness is likely the result of founder mutations in multiple genetic 
isolates. 
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Within many communities the genetic causes of blindness were multiple. For 
example, in the geographic region of Conception Bay, nine different hereditary eye 
diseases were identified, and some were associated with at least two different mutations 
(Bardet-Biedl syndrome and Newfoundland Rod Cone Dystrophy). Some of the diversity 
of inherited eye diseases being observed in each geographic area is the background carrier 
rate for multiple different disorders, but also members of families from specific regions 
may have moved within the province for economic reasons. This can be observed with 
the large New World Island family with ocular albinism, which has now spread out across 
Newfoundland into several communities away from the original focus area (Figure 15). 
This has been documented through provision of clinical genetic services to OA l family 
members in different parts of the province. 
Visual Aids, Counseling, and Genetic Testing: Planning for the future 
Visual aids which improve support for education, employment, and transportation 
for people with reduced vision are of the utmost importance. In children especially even 
the slightest amount of vision allows for the sense of sight to develop and enter into their 
learning processes. The earlier a patient is introduced to visual aids in the course of their 
disease, when their remaining vision is still good, the easier it will be to merely adjust 
magnification in the future as vision decreases. A visual defect may affect an individual 
seriously, becoming an impediment to their social and scholastic progress, and it is vital 
that every attempt to help these individuals be made. 
It is important to provide education about the features of these inherited eye 
conditions, the risk of recurrence to all affected people and their family members, and 
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whether genetic testing is available and when it is appropriate. Genetic counseling is an 
extremely valuable resource for families or individuals who are affected by these 
conditions and are seeking guidance or assistance to help them fit into the mainstream of 
society. Instruction and support from genetic counselors or physicians can be offered to 
all parents of affected children, or to any affected individual. Information can be made 
available for a child affected with a disorder at the appropriate time. Therefore, if a child 
is too young to be informed about their illness, or if the parents would like to defer 
providing information to them at such an early time, then it would be withheld until the 
appropriate time has come. These health care professionals help individuals and families 
understand the cause of the specific disease, as well as addressing the medical, ethical, 
sociological, and psychological issues that are associated with each specific disorder. 
There is an increasing range of genetic tests for an increasing range of heritable 
disorders, which is all made possible by human genome research being completed around 
the world. If a mutation is known then screening/prenatal testing should be offered. 
Especially, in the case of autosomal recessive disorders, carrier screening of family 
members of the affected individual should be offered. 
It will be feasible to produce multiple diagnostic tests for the multiple mutations 
causing blindness in Newfoundland. Thus it may be possible to determine which parents 
carry mutations, and to test pre-symptomatically in children. These scenarios have ethical 
issues, therefore the individuals and their families should be informed about the pros and 
cons of such testing, and the final decision should lie with the person involved, and they 
should have the ability and the right to decline any genetic testing in almost all instances. 
Pre-symptomatic testing is concerned with the analysis of DNA samples taken in 
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early infancy in order to detect genetic diseases and facili tate appropriate interventions 
which can avert or ameliorate adverse outcomes or serious health problems in the future. 
It is of great importance if parents value diagnosis prior to the onset of visual 
deterioration so that this education and intervention can prepare the child and the family 
for a subsequent life with reduced vision. General international opinion about programs 
of genetic testing and screening is represented by the recommendations of the Nuffield 
Council on Bioethics (157). These include the requirement for informed consent and that 
all written information should be supplemented with counseling, individuals and parents 
of unborn or young children should be fully informed of the results of genetic screening 
and their implications for the family (157). The hope is that the general public recognizes 
the benefits and the potential usefulness of genetic testing and screening for individuals, 
for families, and for the population as a whole. However, acknowledging that there is an 
accompanying anxiety that genetic testing and screening arouses, all efforts to minimize 
any future unease should be made including: informing the public in advance, offering 
appropriate counseling, providing equality of access, and respecting the self-
determination of those tested, making testing or screening non-compulsory. 
In recent decades researchers in the province of Newfoundland and Labrador have 
made great strides in understanding the genetic and clinical epidemiology of inherited eye 
diseases. Research in Newfoundland has produced important observations on the clinical 
manifestations and outcomes of Mendelian inherited diseases, as well as mechanistic 
insights into the molecular determinants of the diseases. The molecular causes of many 
inherited diseases have already been identified and several others are currently being 
studied and will be determined in the near future. 
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XI. CONCLUSION 
Investigation within the Newfoundland population has revealed that the 
prevalence of blindness in 1981 caused by monogenic disease was extremely high (0. 76 
per 1 ,000). Long term follow-up, detailed clinical investigation and analysis of extended 
pedigrees has facilitated accurate diagnosis, and demonstrated that multiple different 
causes of inherited blindness within regions were observed. 
Some disorders including Bardet-Biedl Syndrome, Stargardt Disease, Usher 
Syndrome, Retinitis Pigmentosa, Achromatopsia, and Oculocutaneous Albinism occurred 
in many regions of the province, although geographic clustering of several of these 
conditions did occur. Consistent with the idea that Newfoundland is comprised of 
multiple genetic isolates, is that Bardet-Biedl Syndrome occurred in most regions and was 
caused by nine mutations in six different genes. Other rare disorders were observed in 
only one region. 
Geographical mapping of families with autosomal recessive blindness of 
undetermined genetic etiology revealed similar patterns as for Bardet-Biedl Syndrome 
and Stargardt Disease suggesting that in other conditions such as Retinitis Pigmentosa, 
Achromatopsia, Oculocutaneous Albinism, and Usher Syndrome, multiple mutations in 
one or more genes will be discovered. 
The peopling of Newfoundland and Labrador has predisposed to the frequent 
occurrence of inherited blindness, resulting from multiple mutations in different genes. 
The province is comprised of not just one but multiple genetic isolates. The genetic 
architecture of the population has facilitated the identification of novel genes and the 
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potential to determine the genetic basis of other causes of blindness. Geographic 
mapping of cases, with accurate phenotypic description and identification of inheritance 
patterns, may facilitate the identification of novel genes and mutations causing blindness 
in Newfoundland and Labrador. One goal of this genetic research in Newfoundland is the 
identification of novel genes and specific mutations within families, and the development 
of pediatric molecular diagnostic assays for future testing and screening of individuals 
from families with inherited disorders of the eye. 
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A. Anatomy of the Eye 
The human eye is a complex organ, with many structures working together to give 
us the sense of sight, allowing us to observe and learn about the surrounding world. It 
can be divided into two segments, which are anterior and posterior (Figure 7). 
The Anterior Segment 
The anterior segment is the front third of the eye that includes the structures in 
front of the vitreous humour: the cornea, aqueous humour, iris, ciliary body, lens, 
zonules, and pupil (Figure 8). 
The Cornea 
The cornea is the transparent front part of the eye that covers the iris, pupil, and 
anterior chamber. It is a powerful refracting surface providing most of an eye's optical 
power. The cornea is extremely sensitive and has more nerve endings than anywhere else 
in the body. Together with the lens, the cornea refracts light and as a result helps the eye 
to focus ( 14, 158). 
Aqueous Humour 
The aqueous is the tissue fluid that fills the space between the cornea and the iris 
(anterior chamber) and the space between the iris and the front face of the vitreous 
(posterior chamber). It is continually produced by the ciliary body. This fluid nourishes 
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the cornea and the lens, structures that must be transparent and therefore devoid of blood 
vessels. The flow of the aqueous humour provides the appropriate intraocular pressure 
that gives the front ofthe eye its form and shape (159,160). 
The Iris 
The iris consists of pigmented fibrovascular tissue known as a stroma. The stroma 
connects a sphincter muscle (sphincter pupillae), which contracts the pupil, and a set of 
dilator muscles (dilator pupillae) which open it. The back surface is covered by an 
epithelial layer two cells thick (the iris pigment epithelium), but the front surface has no 
epithelium. The outer edge of the iris known as the root is attached to the sclera and the 
anterior ciliary body (17). 
The Pupil 
The pupil is the opening in the center of the iris. It appears black because most of 
the light entering is absorbed by the tissues inside the eye. The size of the pupil 
determines the amount of light that enters the eye. The pupil size is controlled by the 
dilator and sphincter muscles of the iris ( 17). 
The Zonule ofZinn (Suspensory Ligaments) 
The zonule is a ring of fibrous strands connecting the ciliary body with the lens of 
the eye. The zonules hold the lens in place and function to change the focusing power of 
the eye by changing the tension of the zonules by contraction and relaxation of the ciliary 
muscle (19). 
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The Ciliary Muscle 
The ciliary muscle is a smooth muscle that affects zonules in the eye (fibers that 
suspend the lens in position). During accommodation these muscles enable changes in 
the lens shape for light focusing (19). 
The Lens 
The lens or crystalline lens is a transparent, biconvex structure in the eye that 
along with the comea helps to refract light to focus on the retina. The lens is flexible and 
its curvature is controlled by ciliary muscles through the zonules ( 15). 
Conjunctiva 
The conjunctiva is a thin, transparent tissue covering the outer surface of the eye. 
It begins at the outer edge of the comea, covering the visible part of the sclera, and lining 
the inside of the eyelids. The conjunctiva receives nourishment from tiny blood vessels 
and functions to secrete oils and mucous that moisten and lubricate the eye ( 161 ). 
The Posterior Segment 
The posterior segment comprises the remaining intemal structures which lie 
posterior to the anterior segment. This includes: the retina, macula, fovea, sclera, 
choroid, vitreous humour, and optic nerve (Figure 9). 
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The Retina 
The retina is a thin multi-layered transparent membrane of neural cells that lines 
the inner surface of the large posterior segment of the eyeball (20,21 ). It contains 
millions of photoreceptors that capture light rays and convert them into electrical 
impulses which are sent to the brain via the optic nerve and are transformed into images. 
These photoreceptors can be divided into cones and rods. The cones which function best 
in bright light and allow us to appreciate color are concentrated in the macula, particularly 
within the fovea, the very center portion of the macula, the portion of the retina 
responsible for central vision, but are present in decreasing density in the mid-periphery 
and periphery. The rods which function best in dim light are responsible for peripheral 
and night vision, are not present in the macula but are spread throughout the peripheral 
retina (20). 
The retina has ten distinct layers (Figure 24). Starting with the innermost layer to the 
outermost layer, they include (21 ): 
1. Internal limiting membrane 
2. Nerve fiber layer 
3. Ganglion cell layer - Layer that contains nuclei of ganglion cells and gives rise to 
optic nerve fibers. 
4. Inner plexiform layer 
5. Inner nuclear layer 
6. Outer plexiform layer 
7. Outer nuclear layer 
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8. External limiting membrane- Layer that separates the inner segment portions of 
the photoreceptors from their cell nuclei . 
9. Photoreceptor layer- Rod and Cone cells 
10. Retinal pigment epithelium 
8 
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Figure 25. A schematic illustration ofthe ten anatomical /ayers of the retina and choroid. 
(Illustration by Adrienne J. Boutwell and Lisa J. Birmingham © University of Illinois 
Board a/Trustees 2002.) 
The Macula 
The macula is located roughly in the center of the retina, temporal to the optic 
nerve. It is a small and highly sensitive par1 of the retina responsible for detai led central 
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v1s1on. The fovea is the very center of the macula. The macula allows us to appreciate 
detail and perform tasks that require central vision such as reading (20,21). 
The Sclera 
The sclera is commonly known as the white of the eye. It is made of tough fibrin 
connective tissue that serves as the eye's protective outer coat (14). 
The Choroid 
The choroid lies between the retina and sclera. It is the vascular layer of the eye 
that provides oxygen and nourishment to the outer layers of the retina (162). 
The Vitreous Humour 
The vitreous humour is the clear aqueous solution that fills the space between the 
lens and the retina of the eyeball. The solution is 99% water and comprises about 2/3 of 
the eye's volume, giving it form and shape (21 ,24). 
The Optic Nerve 
In each eye the optic nerve connects the retina to target areas of the brain. These 
nerves transmit visual information from the retina to the brain. The optic nerve is not a 
peripheral nerve, but rather it is a white matter tract of the central nervous system (CNS), 
projecting outside the confines of the cranium (25). 
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B. Previous Newfoundland studies: Literature review 
This section will provide an overview of the relevant study findings and the 
clinical work that has been published on several inherited eye diseases in Newfoundland 
such as, Bardet-Biedl Syndrome (BBS), Newfoundland Rod-Cone Dystrophy (NFRCD), 
and Ocular Albinism. The following papers are included: 
1.) Hereditary diseases as causes of blindness in Newfoundland: preliminary report. 
Green JS, Johnson GJ. Canadian Journal of Ophthalmology. 1983 Oct; 18(6): 281-4, 
1983. (147) 
2.) The burden of genetically determined eye disease. Green JS, Bear JC, Johnson GJ. 
The British Journal of Ophthalmology. 1986 Sep; 70(9): 696-9. (148) 
3.) Newfoundland rod-cone dystrophy, an early-onset retinal dystrophy, is caused by 
splice-junction mutations in RLBPl. Eichers ER, Green JS, Stockton DW, Jackman CS, 
Whelan J, McNamara JA, Johnson GJ, Lupski JR, Katsanis N. American Journal of 
Human Genetics. 2002 Apr; 70(4): 955-64. (43) 
4.) Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-
year prospective, population-based, cohort study. Moore SJ, Green JS, Fan Y, Bhogal 
AK, Dicks E, Fernandez BA, Stefanelli M, Murphy C, Cramer BC, Dean JC, Beales PL, 
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Katsanis N, Bassett AS, Davidson WS, Parfrey PS. American Journal of Medical 
Genetics. 2005 Feb 1; 132(4): 352-60. (79) 
5.) Autosomal recessive Bardet-Biedl syndrome: first-degree relatives have no 
predisposition to metabolic and renal disorders. Webb M, Dicks EL, Green J, MooreS, 
Warden G, Gamberg J, Davidson WS, Young T, Parfrey PS. Kidney International. 76(2): 
215-23,2009. (84) 
6.) Ocular albinism in Newfoundland. Johnson GJ, Gillan JG, Pearce WG. Canadian 
Journal ofOphthalmology. 1971 Oct; 6(4): 237-48. (163) 
7.) Genetic mapping ofX-linked ocular albinism: linkage analysis in a large 
Newfoundland kindred. Charles SJ, Green JS, Moore AT, Barton DE, Yates JR. 
Genomics. 1993 Apr; 16(1 ): 259-61. (149) 
"Hereditary diseases as causes of blindness in Newfoundland: preliminary report": 
This paper reports the underlying etiology of blindness for the registered blind 
population in the province of Newfoundland and Labrador in 1981. The authors state that 
accurate statistics on the causes of blindness and the number of people affected is needed 
to direct preventive efforts and to monitor trends in incidence. 
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The records of all l ,013 people registered with the Canadian National Institute of 
the Blind (CNIB) in Newfoundland were reviewed by Dr. Jane Green before December 
31 , 1981. There was an effort made by Dr. Green to establish the underlying pathological 
process or clinical entity rather than the site or secondary effects ofthe lesion. If it was 
observed that the diagnosis differed in the two eyes, the diagnosis for the second eye was 
used. If multiple diagnoses were given in the reviewed reports with no order specified, 
and the person could not be examined for other reasons, then the cause was listed as 
undetermined. The coding used by the CNIB was adapted from the classification of the 
National Society for the Prevention of Blindness. There are separate codes for diagnosis 
(site and type oflesion) and for etiology. Two of the codes for etiology denote probable 
or possible hereditary eye disease. Where there was some ambiguity in the diagnosis or 
etiology, every attempt was made to arrive at the precise diagnosis by examining the 
person, by writing to other ophthalmologists within or outside the province or by 
researching the ancestral pedigree. At the time of this publication, 193 ofthe 1,013 
patients had been examined, with only 41 showing some ambiguity. Also reported was 
that 778 of the 1,013 cases of blindness within the province were unambiguous as to the 
cause of that blindness and agreed with the CNIB codes. 
One major advantage reported in this study was the ability to access local 
information and to examine some of the patients who were in the undetermined category. 
This meant the proportion of cases in the undetermined category was greatly reduced 
compared to other previous studies. 
Finally this paper stresses the importance of providing education about these 
conditions and their prevention to all affected people and their family members. Genetic 
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counseling should be more widely available for the people dealing with these conditions 
as well as visual aids and other educational assistance to help the individuals fit into the 
mainstream of the community. 
"The burden of genetically determined eye disease": 
This paper reports the underlying etiology of blindness for the registered blind 
population in the province ofNewfoundland Labrador in 1984. This is a follow up and 
concluding report to the previous "Hereditary diseases as causes of blindness in 
Newfoundland: preliminary report" paper from 1981. Here the authors show analyses 
comparing the numbers of registrants in 1981 and 1984. It also reports an interest in the 
relative burden to the population of different causes of blindness, and therefore the 
'person-years of blindness' was determined for the different categories as an index of the 
personal and population impact. 
Researchers obtained the ages of death of all registrants dying in the years 1981-
1984, along with their ages at registration. From these numbers they calculated the mean 
ages of registration for each major etiological category, the duration ofblindness to the 
nearest whole year of each deceased registrant, and the mean duration of blindness for 
each major etiological category. For comparison the mean ages of registration for all 
registrants and for those first registered in the last five years were calculated. For each 
etiological category they multiplied the mean duration of blindness for deceased 
registrants (1981-1984) by the overall number of patients in the category as at December 
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31st 1984 to arrive at "person years of blindness", an indicator of the relative burden to 
the population of each major cause of blindness. 
The overall individual and population impact of monogenic blindness is 
overwhelmingly greater than that fo r all other causes because of the much younger age of 
registration (25 years on average) and long survival with blindness (2 1 years on average 
of"person years of blindness"). The researchers stress that while it remains of great 
importance to provide support through low-vision services, itinerant teachers for the 
visually impaired, and employm ent counseling, much more attention should be paid to 
elucidating the genetic component of blindness. 
"Newfoundland rod-cone dystrophy, an early-onset retinal dystrophy, is caused by 
splice-junction mutations in RLBPI " : 
This paper reports on a specific retinal dystrophy in Newfoundland consistent 
with retinitis punctata albescens but with a substantially lower age at onset and more-
rapid and distinctive progression, a disorder tenn ed "Newfoundland Rod-Cone 
Dystrophy" (NFRCD). Symptoms such as night blindness were evident during infancy; 
fo llowed by the progressive loss of peripheral, central, and colour vision during 
childhood. Severe loss of vision is seen by the 2 nd to 4 th decade of life. 
Twenty-six patients (ages 5 years to 56 years) from six famil ies were ascertained 
through 12 pro bands referred to the Memorial University of Newfoundland Ocular 
Genetics Clinic. It is reported that 19 of these patients had lived within a I 0-mile radius 
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of each other in a Newfoundland area that, until recently, had remained isolated, being 
settled during the mid-18th century by immigrants from southwestern England. In an 
attempt to identify any connection between families a detailed history of each of the 
families was obtained from each proband. Older relatives within the families were 
interviewed, as well as archives being searched. However, a single common ancestor was 
not identified. 
Most of the 26 subjects had been followed for more than 22 years, with 
ophthalmological examination, visual-field testing, color-vision testing, dark-adaptation 
testing, electroretinography (ERG), retinal photography, and fluorescein angiography. 
Blood samples for DNA extraction were also collected. 
The size of one ofthe families was sufficiently large (15 persons) to allow the 
researchers to perfonn a genomewide screen to map the NFRCD locus. Significant 
linkage to markers on the long ann of chromosome 15 (15q26 section), in a region 
encompassing RLBP 1 was detected. This gene is involved with encoding the cellular 
retinaldehyde- binding protein. As stated in previous reports cited throughout this paper , 
mutations in RLBP 1 have been associated with other retinal dystrophies such as Bothnia 
dystrophy, retinitis punctata albescens, retinitis pigmentosa, and fundus albipunctatus, 
which led to the researchers hypothesizing that RLBP 1 mutations might also cause 
NFRCD. 
To test their hypothesis researchers sequenced the seven coding exons and splice 
junctions of RLBP f. They detected two sequence alterations, both likely to be 
pathogenic, since each segregated with the disease and was predicted to interfere with 
mRNA splicing. They stated that in contrast to some previously reported RLBP 1 
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mutations, which yielded a protein that may retain some residual activity, each NFRCD 
mutation was likely to give rise to a null allele. This difference may account for the 
severe phenotype in these families and exemplifies the molecular continuum that 
underlies clinically distinct but genetically related entities . 
The two alterations found were: 1) a G-A transition (324G-A) in the last base 
of exon 3, and 2) aT -c transition in the second base of intron 3 (IVS3+2 T -C). 
Comparison of the haplotypes of the disease-carrying chromosomes in the six pedigrees 
also reveals two distinct haplotypes associated with the 3240-A mutation and two 
haplotypes associated with the IYS3+2 T - c mutation. This suggests either that both 
mutations were introduced into Newfoundland through two independent mutation events 
on two different chromosomes or that each mutation is relatively old and has undergone 
haplotype divergence. 
"Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 
22-year prospective, population-based, cohort study": 
This paper is a prospective, population-based study, with comprehensive 
ascertainment, and follow-up for 22 years. The objectives of the study were: (a) to 
determine if Bardet-Biedl syndrome (BBS) and Laurence-Moon syndrome (LMS) are a 
single disorder, (b) to describe the epidemiology of BBS, (c) to extend the phenotype, and 
(d) to determine ifthere are genotype-phenotype correlations in BBS. 
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This study's cohort involved 46 patients, 26 being male and the remaining 20 
female, from 26 families throughout the province. The reported range of age was 1.5 
years to 67.9 years, with a median age of 44 years. To be enrolled in this study the 
patients must have had a retinal dystrophy and other features suggestive of BBS, such as 
renal structural abnonnalities, obesity, dysmorphic extremities, and hypogenitalism. 
The identification of affected patients started in 1979, with the initial and most 
significant tool being the registry of the CNIB. These patients gained registry as a result 
of their attendance at an Ocular Genetics Clinic, or through subsequent family studies 
completed. Hospitals were also canvassed for patients having any mention in their 
medical records as having BBS or LMS, however no new patients were located. 
The prevalence of BBS in Newfoundland at the time of this study was 
approximately 1 in 18,000. This is significantly higher than other populations around the 
world as determined by a study from 1970 on BBS in Switzerland which reported a 
prevalence of 1 in 160,000. It is reported that 31 percent of the people in the 26 families 
involved in the Newfoundland study were affected. Founder effects, consanguinity, and 
large sibship size likely increased the prevalence ofBBS in Newfoundland. 
The results of the study show the following known BBS loci and the number of 
patients involved with each: eight patients have mutations in BBSJ , one has a mutation in 
BBS2, five have mutations in BBS3, five have mutations in BBS5, and fifteen have 
mutations in BBS6. There were six patients excluded from all eight known BBS loci 
because the molecular investigations were inconclusive due to family structure. Six 
patients were excluded from the analysis due to no DNA being available. 
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This study gives evidence that BBS and LMS should be considered the same 
disorder. Through comprehensive ascertainment, the researchers involved attempted to 
identify all the cases ofboth disorders within Newfoundland. Two of the 46 patients met 
the criteria for LMS; however, they had mutations in BBS genes. This implies that the 
underlying molecular basis of both BBS and LMS is the same. 
The clinical manifestations observed in the 46 patients included: blindness, 
dystrophy of extremities, obesity, diabetes mellitus, hypertension, renal abnormalities, 
genital and reproductive abnormalities, neurological, speech, and psychiatric 
abnormalities, craniofacial dysmorphology, gall stone disease, colonic disorders, asthma, 
congenital heart disease, early death, and other miscellaneous disorders. The 
abnormalities in most organs of the human body are consistent with defects in the 
terminal maturation of organs. 
"Metabolic and Renal Events in Autosomal Recessive Bardet-Biedl (BBS) Syndrome 
and in First Degree Relatives With and Without a BBS Mutation: A population and 
family based study": 
Researchers involved with this report state they have now identified the molecular 
genetic cause ofBBS in all cases in Newfoundland from whom DNA has been collected. 
[n addition they have determined which first or second degree relatives of cases are and 
are not carriers of a BBS mutation. They have perfonned the fourth assessment of these 
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cases over 28 years of prospective follow-up, and investigated first degree relatives for 
the first time. 
Forty-six cases from members of 26 families were identified. Of 136 siblings, 
35% had BBS. DNA was obtained from 21 families, and the molecular genetic cause of 
the disease was identified in all cases, amounting to nine mutations in six BBS genes 
being identified. The researchers conclude that the high prevalence of BBS in 
Newfoundland is likely the result of the high coefficient of kinship in multiple genetic 
isolates and the frequency with which different pathogenic BBS mutations may occur. 
"Ocular albinism in Newfoundland": 
This publication reports the initial discovery of ocular albinism within 
ewfoundland. A large family (200 persons) located in the New World Islands area, in 
Notre Dame Bay, just off the north east coast of the province, was identified and a 
pedigree of six generations was traced back to a woman who lived in Moreton's Harbour, 
approximately 130 years ago. This family stemmed from early settlers who came from 
England. During examination of ten affected males it was found that all had features 
described for ocular albinism, which included: impaired visual acuity, photophobia, 
nystagmus and a generalized deficiency of pigment in the retinal pigment epithelium. 
From previous studies, this condition was known to be due to an abnormal gene on the X 
chromosome. Males, with only one X chromosome show the full effect of the mutant 
gene, while females known to be carrying the abnormal gene on one of their two X 
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chromosomes (heterozygote carrier) have no functional disability but may show a patchy 
alteration in retinal pigmentation. Usually the term "carrier" is defined on the basis of 
genetic and not phenotypic status, however in this study it was stated this way and one 
goal of the study was to establish that the patchy depigmentation seen in the "carriers" 
was a reliable indicator of the heterozygote state. Unaffected individuals have neither the 
functional disability nor show any alteration in retinal pigmentation. 
Results reported indicate that a total of 29 affected males along with 50 carrier 
females were examined. The progeny of affected males were reported as male children 
not showing any ocular impairment, with results stating there were 40 unaffected sons 
and no affected sons, while all female children showed signs of a patchy alteration in 
retinal pigment, with results reporting 26 carrier daughters and no unaffected daughters. 
The progeny of carrier females were reported showing many children with the presence 
and absence of an ocular impairment or a patchy alteration in retinal pigment, with results 
stating there were 40 affected sons and 28 unaffected sons, as well as 20 carrier daughters 
and 28 unaffected daughters. 
The majority of affected individuals had a visual acuity of20/200 or less and were 
registered as blind. It was reported that reading vision was in general not so severely 
affected as distance vision, which causes considerable problems for children, having to 
hold books very close to their face and having trouble reading a blackboard in school. 
Although their vision was on the borderline of legal blindness, some affected individuals 
were able to work satisfactorily in the fishing or forestry industries as the requirements 
for excellent acuity were not as great as newly introduced trades. The investigators 
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stressed that unless the next generation of individuals decides to limit its reproduction, the 
number of people have ocular albinism in the future will increase considerably. 
"Genetic mapping of X-linked ocular albinism: linkage analysis in a large 
Newfoundland kindred": 
This short communication reports on a genetic linkage study in a large 
Newfoundland family affected by X-linked ocular albinism (OAl). The family as 
reported in a previous publication "Ocular albinism in Newfoundland" is from the New 
World Island area, in Notre Dame Bay, just off the north east coast of the province. 
X-linked ocular albinism is stated to cause reduction is visual acuity and nystagmus in 
males, associated with iris translucency and foveal hypoplasia. Carrier females have 
normal vision, but ophthalmic examination may show a characteristic "mud-splattered" 
fundus appearance. Venous blood samples were obtained from 91 individuals (including 
18 affected males, and 36 obligate carriers females) for DNA extraction and Xg blood 
grouping. The Xg blood group system, a classification of human blood based on the 
presence of proteins called Xg antigens on the surfaces of red blood cells, was used since 
this is the only blood group in which the antigen-encoding genes are located on the X 
chromosome. Discovery of the Xg system in 1962 greatly aided mapping of the X 
chromosome (164). 
The researchers used DNA markers DXS237, DXS 143, and DXS85 during the 
study. Results reported from this analysis showed linkage to markers from chromosome 
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Xp22.3. Also one recombinant mapped the disease proximal to DXS143 and two 
recombinants mapped the disease distal to DXS85. These results are confirmed with 
other studies involving 16 British families also showing close linkage between OA 1 and 
DXS 143. 
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